Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.


Funktionen

  • Direktor/in, Innere Klinik (Tumorforschung)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel; Kimmich, Martin; Deuß, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbücher, Frank; Eberhardt, Wilfried
    A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer
    In: Therapeutic Advances in Medical Oncology Jg. 13 (2021) in press
    ISSN: 1758-8359; 1758-8340
  • Metzenmacher, Martin; Goetz, Moritz; Herold, Thomas; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Eberhardt, Wilfried; Schuler, Martin; Wiesweg, Marcel
    Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V⁶⁰⁰-mutated Squamous Cell Lung Cancer: Concurrent Evolvement of PTEN and MEK1 Mutations
    In: Clinical Lung Cancer (2021)
    ISSN: 1938-0690; 1525-7304
  • Mrotzek, Simone M.; Lena, Alessia; Hadzibegovic, Sara; Ludwig, Ria; Al-Rashid, Fadi; Mahabadi, Amir Abbas; Mincu, Raluca I.; Michel, Lars; Johannsen, Laura; Hinrichs, Lena; Schuler, Martin; Keller, Ulrich; Anker, Stefan D.; Landmesser, Ulf; Rassaf, Tienush; Anker, Markus S.; Totzeck, Matthias
    Assessment of coronary artery disease during hospitalization for cancer treatment
    In: Clinical Research in Cardiology Jg. 110 (2021) S. 200 - 210
    ISSN: 1861-0692; 1861-0684
  • Wiesweg, Marcel; Preuß, Cedric; Roeper, Julia; Metzenmacher, Martin; Eberhardt, Wilfried; Stropiep, Ursula; Wedeken, Katrin; Reis, Henning; Herold, Thomas; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schmid, Kurt Werner; Falk, Markus; Heukamp, Lukas; Tiemann, Markus; Griesinger, Frank; Schuler, Martin
    BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy
    In: European Journal of Cancer Jg. 149 (2021) S. 211 - 221
    ISSN: 1879-0852; 0959-8049
  • Frikkel, J.; Beckmann, Mingo B.; de Lazzari, N.; Götte, Miriam; Kasper, Stefan; Hense, Jörg; Schuler, Martin; Teufel, Martin; Tewes, Mitra
    Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months : A comparative study
    In: Supportive Care in Cancer (2021) in press
    ISSN: 1433-7339; 0941-4355
  • Markus, M.; Abendroth, Annalena; Noureddine, R.; Paul, Andreas; Breitenbuecher, Sandra; Virchow, Isabel; Schmid, Kurt Werner; Markus, Peter; Schumacher, Brigitte M.; Wiesweg, Marcel; Wendling, Johanna; Mende, Bastian; Siveke, Jens; Schuler, Martin; Kasper, Stefan
    Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy
    In: Journal of Cancer Research and Clinical Oncology Jg. 147 (2021) Nr. 2, S. 579 - 591
    ISSN: 1432-1335; 0171-5216
  • Schuler, Martin
    Corrigendum to “Inhibiting fibroblast growth factor receptors in cancer – The next generation”
    In: Annals of Oncology Jg. 32 (2021) Nr. 1, S. 126
    ISSN: 1569-8041; 0923-7534
  • Guberina, Maja; Sak, Ali; Pöttgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Von der Grün, Jens; Rödel, Claus Michael; Gkika, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephani E.; Mönnich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Höing, Benedikt; Lang, Stephan; Stuschke, Martin
    ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    In: The Pharmacogenomics Journal Jg. 21 (2021) Nr. 1, S. 37 - 46
    ISSN: 1473-1150; 1470-269X
  • Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Ploenes, Till; Pöttgen, Christoph; Guberina, Nika; Herrmann, Ken; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Stuschke, Martin
    Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC
    In: European Journal of Nuclear Medicine and Molecular Imaging (2021) in press
    ISSN: 1619-7089; 1619-7070
  • Chih-Hsin Yang, J.; Schuler, Martin; Popat, S.; Miura, S.; Heeke, S.; Passaro, A.; de Marinis, F.; Park, K.; Kim, E.S.
    MO01.36 Afatinib in Asian and Non-Asian Patients (pts) with EGFR Mutation-Positive (EGFRm+) NSCLC Harboring Major Uncommon Mutations
    In: Journal of Thoracic Oncology Jg. 16 (2021) Nr. 1, S. 31
    ISSN: 1556-0864; 1556-1380
  • Zaun, Gregor; Schuler, Martin
    Systemische Tumortherapien des CUP-Syndroms
    In: Der Onkologe (2021)
    ISSN: 0947-8965; 1433-0415
  • Yang, James Chih-Hsin; Schuler, Martin; Popat, Sanjay; Miura, Satoru; Heeke, Simon; Park, Keunchil; Märten, Angela; Kim, Edward S.
    Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations : A Database of 693 Cases
    In: Journal of Thoracic Oncology Jg. 15 (2020) Nr. 5, S. 803 - 815
    ISSN: 1556-1380; 1556-0864
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Höhler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Reis, Henning; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kostbade, Karina; Virchow, Isabel; Ting, Saskia; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Wiesweg, Marcel; Schuler, Martin; Trarbach, Tanja
    Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX Trial
    In: Clinical Colorectal Cancer Jg. 19 (2020) Nr. 4, S. 236 - 247.e6
    ISSN: 1938-0674; 1533-0028
  • Welt, Anja; Wiesweg, Marcel; Theurer, Sarah; Abenhardt, Wolfgang; Groschek, Matthias; Müller, Lothar; Schröder, Jan; Tewes, Mitra; Chiabudini, Marco; Potthoff, Karin; Bankfalvi, Agnes; Marschner, Norbert; Schuler, Martin; Breitenbücher, Frank
    Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
    In: Cancer Medicine Jg. 9 (2020) Nr. 13, S. 4527 - 4539
    ISSN: 2045-7634
  • Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin
    Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation
    In: Lung Cancer Jg. 139 (2020) S. 165 - 168
    ISSN: 1872-8332; 0169-5002
  • Bilecz, Agnes; Stockhammer, Paul; Theegarten, Dirk; Kern, Izidor; Jakopovic, Marko; Samarzija, Miroslav; Klikovits, Thomas; Hoda, Mir A.; Döme, Balázs; Oberndorfer, Felicitas; Muellauer, Leonhard; Fillinger, János; Kovács, Ildikó; Pirker, Christine; Schuler, Martin; Plönes, Till; Aigner, Clemens; Klepetko, Walter; Berger, Walter; Brcic, Luka; Laszlo, Viktória; Hegedus, Balazs
    Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
    In: Histopathology Jg. 77 (2020) Nr. 1, S. 55 - 66
    ISSN: 1365-2559; 0309-0167
  • Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Krebs, Bettina; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Jöckel, Karl-Heinz; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Eberhardt, Wilfried
    Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improve
    In: European Journal of Cancer Jg. 138 (2020) S. 156 - 168
    ISSN: 1879-0852; 0959-8049
  • Guberina, Maja; Sak, Ali; Pöttgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Von der Grün, Jens; Rödel, Claus Michael; Gkika, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie E.; Mönnich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Höing, Benedikt; Lang, Stephan; Stuschke, Martin
    Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    In: The Pharmacogenomics Journal (2020) in press
    ISSN: 1473-1150; 1470-269X
  • Wiesweg, Marcel; Schuler, Martin; Schildhaus, Hans-Ulrich
    Crizotinib in ROS1 and MET deregulated NSCLC-letter
    In: Clinical Cancer Research: an official journal of the American Association for Cancer Research Jg. 26 (2020) Nr. 7, S. 1774
    ISSN: 1557-3265; 1078-0432
  • Stockhammer, Paul; Ploenes, Till; Theegarten, Dirk; Schuler, Martin; Maier, Sandra; Aigner, Clemens; Hegedus, Balazs
    Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma
    In: Lung Cancer Jg. 139 (2020) S. 124 - 132
    ISSN: 1872-8332; 0169-5002
  • Guberina, Maja; Sak, Ali; Pöttgen, Christoph; Tinhofer-Keilholz, Ingeborg; Budach, Volker; Balermpas, Panagiotis; Von der Grün, Jens; Rödel, Claus Michael; Gikka, Eleni; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie; Mönnich, David; Zips, Daniel; De-Colle, Chiara; Welz, Stefan; Linge, Annett; Lohaus, Fabian; Baretton, Gustavo; Gauler, Thomas; Baumann, Michael; Krause, Mechthild; Schuler, Martin; Bankfalvi, Agnes; Höing, Benedikt; Lang, Stephan; Stuschke, Martin
    ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
    In: The Pharmacogenomics Journal Jg. 21 (2020) Nr. 1, S. 37 - 46
    ISSN: 1470-269X; 1473-1150
  • Reissig, Timm M.; Sara, Linda; Ting, Saskia; Reis, Henning; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Herold, Thomas; Aigner, Clemens; Darwiche, Kaid; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel
    ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer
    In: Lung Cancer Jg. 149 (2020) S. 10 - 16
    ISSN: 1872-8332; 0169-5002
  • Peuker, CA; Yaghobramzi, S; Lüftner, D.; Brucker, S; Decker, T; Fasching, P; Fehm, T; Janni, W; Kümmel, Sherko; Schneeweiss, A; Schuler, Martin; Busse, A
    Einfluss des CDK4/6-Inhibitors Ribociclib auf die periphere Immunantwort beim Hormonrezeptor-positiven Mammakarzinom
    In: Geburtshilfe und Frauenheilkunde Jg. 80 (2020) Nr. 6, S. e53
    ISSN: 1438-8804; 0016-5751
  • Frikkel, Johanna; Götte, Miriam; Beckmann, Mingo B.; Kasper, Stefan; Hense, Jörg; Teufel, Martin; Schuler, Martin; Tewes, Mitra
    Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients
    In: BMC Palliative Care Jg. 19 (2020) Nr. 1, S. 43
    ISSN: 1472-684X
  • Nothdurft, Silke; Thumser-Henner, Clotilde; Breitenbücher, Frank; Okimoto, Ross A.; Dorsch, Madeleine; Opitz, Christiane A.; Sadik, Ahmed; Esser, Charlotte; Hölzel, Michael; Asthana, Saurabh; Forster, Jan; Beisser, Daniela; Kalmbach, Sophie; Grüner, Barbara M.; Bivona, Trever G.; Schramm, Alexander; Schuler, Martin
    Functional screening identifies aryl hydrocarbon receptor as suppressor of lung cancer metastasis
    In: Oncogenesis Jg. 9 (2020) Nr. 11, S. 102
    ISSN: 2157-9024
  • Stockhammer, Paul; Ho, Cassandra Su Lyn; Hegedus, Luca; Lotz, Gabor; Molnár, Eszter; Bankfalvi, Agnes; Herold, Thomas; Kalbourtzis, Stavros; Ploenes, Till; Eberhardt, Wilfried; Schuler, Martin; Aigner, Clemens; Schramm, Alexander; Hegedus, Balazs
    HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
    In: Lung Cancer: Journal of the International Association for the Study of Lung Cancer Jg. 144 (2020) S. 20 - 29
    ISSN: 1872-8332; 0169-5002
  • Welt, Anja; Bogner, Simon; Arendt, Marina; Kossow, Josef; Huffziger, Antonia; Pohlkamp, Christian; Steiniger, Heike; Becker, Ute; Alashkar, Ferras; Kohl, Marzena; Wiesweg, Marcel; Richly, Heike; Hense, Jörg; Scheulen, Max Ernst; Schuler, Martin; Seeber, Siegfried; Tewes, Mitra
    Improved survival in metastatic breast cancer : results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
    In: Journal of Cancer Research and Clinical Oncology (2020)
    ISSN: 1432-1335; 0171-5216
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Kollmeier, Jens; Misch, Daniel; Stephan-Falkenau, Susann; Mairinger, Thomas; Walter, Robert F.H.; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Köster, Johannes; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
    In: European Journal of Cancer Jg. 140 (2020) S. 76 - 85
    ISSN: 1879-0852; 0959-8049
  • Schuler, Martin; Berardi, Rossana; Lim, Darren Wan Teck; de Jonge, Maja J. A.; Bauer, Todd M.; Azaro, Analía; Gottfried, Maya; Han, Jiyoun; Lee, Dae-hee; Wollner, M.; Hong, David S.; Vogel, Arndt; Delmonte, Angelo; Akimov, Mikhail; Ghebremariam, Samson; Cui, X.; Nwana, N.; Giovannini, Monica; Kim, Tae-min
    Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer : Clinical and biomarker results from a phase I trial
    In: Annals of Oncology (2020)
    ISSN: 1569-8041; 0923-7534
  • Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette
    Phase 1 study of capmatinib in MET-positive solid tumor patients : Dose escalation and expansion of selected cohorts
    In: Cancer Science: The official journal of the Japanese Cancer Association Jg. 111 (2020) Nr. 2, S. 536 - 547
    ISSN: 1349-7006; 1347-9032
  • Bardia, Aditya; Gounder, Mrinal; Rodon, Jordi; Janku, Filip; Lolkema, Martijn P.; Stephenson, Joe J.; Bedard, Philippe L.; Schuler, Martin; Sessa, Cristiana; LoRusso, Patricia; Thomas, Michael; Maacke, Heiko; Evans, Helen; Sun, Yongjian; Tan, Daniel S.W.
    Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations
    In: The Oncologist: The international peer-reviewed journal for the practicing oncologist, hematologist Jg. 24 (2020) S. E160 - E169
    ISSN: 1549-490X; 2159-8401; 1083-7159
  • Metzenmacher, Martin; Váraljai, Renáta; Hegedüs, Balazs; Cima, Igor; Forster, Jan; Schramm, Alexander; Scheffler, Björn; Horn, Peter; Klein, Christoph A.; Szarvas, Tibor; Reis, Henning; Bielefeld, Nicola; Rösch, Alexander; Aigner, Clemens; Kunzmann, Volker; Wiesweg, Marcel; Siveke, Jens; Schuler, Martin; Lueong, Smiths S.
    Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancer
    In: Cancers Jg. 12 (2020) Nr. 2, S. 353
    ISSN: 2072-6694
  • Such, Lina; Zhao, Fang; Liu, Derek; Thier, Beatrice; Le-Trilling, Vu Thuy Khanh; Sucker, Antje; Coch, Christoph; Pieper, Natalia; Howe, Sebastian; Bhat, Hilal; Kalkavan, Halime; Ritter, Cathrin; Brinkhaus, Robin; Ugurel, Selma; Köster, Johannes; Seifert, Ulrike; Dittmer, Ulf; Schuler, Martin; Lang, Karl S.; Kufer, Thomas A.; Hartmann, Gunther; Becker, Jürgen; Horn, Susanne; Ferrone, Soldano; Liu, David; Van Allen, Eliezer M.; Schadendorf, Dirk; Griewank, Klaus; Trilling, Mirko; Paschen, Annette
    Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy
    In: The Journal of Clinical Investigation Jg. 130 (2020) Nr. 8, S. 4266 - 4281
    ISSN: 1558-8238; 0021-9738
  • Schuler, Martin
    The quest for efficient trial designs in precision oncology
    In: The Lancet Oncology Jg. 21 (2020) Nr. 12, S. 1539 - 1541
    ISSN: 1474-5488; 1470-2045
  • Ghanim, Bahil; Rosenmayr, Anna; Stockhammer, Paul; Vogl, Melanie; Celik, Ali; Bas, Aynur; Kurul, Ismail Cuneyt; Akyurek, Nalan; Varga, Alexander; Plönes, Till; Bankfalvi, Agnes; Hager, Thomas; Schuler, Martin; Hackner, Klaus; Errhalt, Peter; Scheed, Axel; Seebacher, Gernot; Hegedus, Balazs; Stubenberger, Elisabeth; Aigner, Clemens
    Tumour cell PD-L1 expression is prognostic in patients with malignant pleural effusion : the impact of C-reactive protein and immune-checkpoint inhibition
    In: Scientific Reports Jg. 10 (2020) Nr. 1, S. 5784
    ISSN: 2045-2322
  • Türeci, Özlem; Sahin, Ugur; Schulze-Bergkamen, Henning; Zvirbule, Zanete; Lordick, Florian; Koeberle, Dieter; Thuss-Patience, Peter C.; Ettrich, Thomas J.; Arnold, Dirk; Bassermann, Florian; Al-Batran, Salah Eddin; Wiechen, K.; Dhaene, Karl F. L.; Maurus, D.; Gold, M.; Huber, Christopher H.; Krivoshik, Andrew P.; Arozullah, A.; Park, J. W.; Schuler, Martin
    A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus : the MONO study
    In: Annals of Oncology Jg. 30 (2019) Nr. 9, S. 1487 - 1495
    ISSN: 1569-8041; 0923-7534
  • Taylor, Matthew H.; Gainor, Justin F.; Hu, Mimi I-Nan; Zhu, Viola Weijia; Lopes, Gilberto; Leboulleux, Sophie; Brose, Marcia S.; Schuler, Martin; Bowles, Daniel W.; Kim, Dong-Wan; Baik, Christina S; Garralda, Elena; Lin, Chia-Chi; Adkins, Douglas; Sarker, Debashis; Curigliano, Giuseppe; Zhang, Hui; Clifford, Corinne; Turner, Christopher D.; Subbiah, Vivek
    Activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients with advanced RET-altered thyroid cancers
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15_Suppl, S. 6018
    ISSN: 0732-183X; 1527-7755
  • Juric, Dejan; Janku, Filip; Rodón, Jordi; Burris, Howard A.; Mayer, Ingrid A.; Schuler, Martin; Seggewiss-Bernhardt, Ruth; Gil-Martin, Marta; Middleton, Mark R.; Baselga, José; Bootle, Douglas; Demanse, David; Blumenstein, Lars; Schumacher, Karl; Huang, Alan; Quadt, Cornelia; Rugo, Hope S.
    Alpelisib Plus Fulvestrant in PIK3CA -Altered and PIK3CA -Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer : A Phase 1b Clinical Trial
    In: JAMA Oncology Jg. 5 (2019) Nr. 2, S. e184475
    ISSN: 2374-2445; 2374-2437
  • Totzeck, Matthias; Schuler, Martin; Stuschke, Martin; Heusch, Gerd; Rassaf, Tienush
    Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease
    In: International Journal of Cardiology Jg. 280 (2019) S. 163 - 175
    ISSN: 0167-5273; 1874-1754
  • Pöttgen, Christoph; Kleinhans, J.; Gauler, Thomas; Wrede, Karsten; Schuler, Martin; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin
    Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic Importance
    In: Strahlentherapie und Onkologie Jg. 195 (2019) Nr. Suppl. 1, S. S66 - S67
    ISSN: 0179-7158; 1439-099X
  • Subbiah, Vivek; Gervais, Radj; Riely, Gregory; Hollebecque, Antoine; Blay, Jean-Yves; Felip, Enriqueta; Schuler, Martin; Gonçalves, Anthony; Italiano, Antonio; Keedy, Vicki; Chau, Ian; Puzanov, Igor; Raje, Noopur S.; Meric-Bernstam, Funda; Makrutzki, Martina; Riehl, Todd; Pitcher, Bethany; Baselga, Jose; Hyman, David M.
    Efficacy of vemurafenib in patients with non–small-cell lung cancer with BRAF V600 mutation : An open-label, single-arm cohort of the histology-independent VE-Basket study
    In: JCO Precision Oncology Jg. 3 (2019) in press
    ISSN: 2473-4284
  • Schuler, Martin; Paz-Ares, Luis; Sequist, Lecia V.; Hirsh, Vera; Lee, Ki Hyeong; Wu, Yi-Long; Lu, Shun; Zhou, Caicun; Feng, Jifeng; Ellis, Stuart H.; Samuelsen, Carl H.; Tang, Wenbo; Märten, Angela; Ehrnrooth, Eva; Park, Keunchil; Yang, James Chih-Hsin
    First-line afatinib for advanced EGFRm+ NSCLC : Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
    In: Lung Cancer Jg. 133 (2019) S. 10 - 19
    ISSN: 1872-8332; 0169-5002
  • Schuler, Martin; Tan, Eng-Huat; O’Byrne, Kenneth; Zhang, Li; Boyer, Michael; Mok, Tony; Hirsh, Vera; Yang, James Chih-Hsin; Lee, Ki Hyeong; Lu, Shun; Shi, Yuankai; Kim, Sang-We; Laskin, Janessa; Kim, Dong-Wan; Arvis, Catherine Dubos; Kölbeck, Karl; Massey, Dan; Märten, Angela; Paz-Ares, Luis; Park, Keunchil
    First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7) : impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression
    In: Journal of Cancer Research and Clinical Oncology Jg. 145 (2019) Nr. 6, S. 1569 - 1579
    ISSN: 1432-1335; 0171-5216
  • Joos, Stefan; Nettelbeck, Dirk M.; Reil-Held, Anette; Engelmann, Katja; Moosmann, Alexandra; Eggert, Angelika; Hiddemann, Wolfgang; Krause, Mechthild; Peters, Christoph; Schuler, Martin; Schulze-Osthoff, Klaus; Serve, Hubert; Wick, Wolfgang; Puchta, Josef; Baumann, Michael
    German Cancer Consortium (DKTK) : A national consortium for translational cancer research
    In: Molecular Oncology Jg. 13 (2019) Nr. 3, S. 535 - 542
    ISSN: 1878-0261; 1574-7891
  • Wiesweg, Marcel; Kasper, Stefan; Worm, Karl; Herold, Thomas; Reis, Henning; Sara, Linda; Metzenmacher, Martin; Abendroth, Annalena; Darwiche, Kaid; Aigner, Clemens; Wedemeyer, Heiner; Helfritz, Fabian A.; Stuschke, Martin; Schumacher, Brigitte; Markus, Peter; Paul, Andreas; Rahmann, Sven; Schmid, Kurt Werner; Schuler, Martin
    Impact of RAS mutation subtype on clinical outcome : a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
    In: Oncogene Jg. 38 (2019) Nr. 16, S. 2953 - 2966
    ISSN: 0950-9232; 1476-5594
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Wiesweg, Marcel; Köhler, Johannes; Markus, M.; Mende, B.; Dechene, Alexander; Schuler, Martin; Kasper, Stefan
    Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols
    In: Journal of Cancer Research and Clinical Oncology Jg. 145 (2019) Nr. 2, S. 445 - 455
    ISSN: 1432-1335; 0171-5216
  • Cheufou, Danjouma Housmanou; Valdivia, Daniel; Puhlvers, Stephan; Fels, Benjamin; Weinreich, Gerhard; Taube, Christian; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Hegedus, Balazs; Stamatis, Georgios; Aigner, Clemens
    Lymph Node Involvement and the Surgical Treatment of Thymic Epithelial and Neuroendocrine Carcinoma
    In: The Annals of Thoracic Surgery Jg. 107 (2019) Nr. 6, S. 1632 - 1638
    ISSN: 1552-6259; 0003-4975
  • Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Walter, Robert; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; McCutcheon, A.; Köster, J.; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin
    Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer
    In: Annals of Oncology Jg. 30 (2019) Nr. 4, S. 655 - 657
    ISSN: 1569-8041; 0923-7534
  • Al-Batran, Salah-Eddin; Homann, Nils; Pauligk, Claudia; Goetze, Thorsten O.; Meiler, Johannes; Kasper, Stefan; Kopp, Hans-Georg; Mayer, Frank; Haag, Georg Martin; Luley, Kim; Lindig, Udo; Schmiegel, Wolff; Pohl, Michael; Stoehlmacher, Jan; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Fischbach, Wolfgang; Mahlberg, Rolf; Trojan, Jörg; Koenigsmann, Michael; Martens, Uwe M.; Thuss-Patience, Peter; Egger, Matthias; Block, Andreas; Heinemann, Volker; Illerhaus, Gerald; Moehler, Markus; Schenk, Michael; Kullmann, Frank; Behringer, Dirk M.; Heike, Michael; Pink, Daniel; Teschendorf, Christian; Löhr, Carmen; Bernhard, Helga; Schuch, Gunter; Rethwisch, Volker; Weikersthal, Ludwig Fischer von; Hartmann, Jörg T.; Kneba, Michael; Daum, Severin; Schulmann, Karsten; Weniger, Jörg; Belle, Sebastian; Gaiser, Timo; Oduncu, Fuat S.; Güntner, Martina; Hozaeel, Wael; Reichart, Alexander; Jäger, Elke; Kraus, Thomas; Mönig, Stefan; Bechstein, Wolf O.; Schuler, Martin; Schmalenberg, Harald; Hofheinz, Ralf D.
    Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4) : a randomised, phase 2/3 trial
    In: The Lancet Jg. 393 (2019) Nr. 10184, S. 1948 - 1957
    ISSN: 0140-6736; 0023-7507; 1474-547X
  • Guberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph
    Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trial
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447
    ISSN: 1619-7089; 1619-7070; 0340-6997
  • Guberina, M.; Stuschke, Martin; Eberhardt, Wilfried; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Dirk, T.; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph
    Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. 146 - S147
    ISSN: 1879-355X
  • Schuler, Martin; Cho, Byoung Chul; Sayehli, Cyrus Michael; Navarro, Alejandro; Soo, Ross A.; Richly, Heike; Cassier, Philippe Alexandre; Tai, David; Penel, Nicolas; Nogova, Lucia; Park, Se Hoon; Schostak, Martin; Gajate, Pablo; Cathomas, Richard; Rajagopalan, Prabhu; Grevel, Joachim; Bender, Sebastian; Boix, Oliver; Nogai, Hendrik; Ocker, Matthias; Ellinghaus, Peter; Joerger, Markus
    Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression : a phase 1 dose-escalation and dose-expansion study
    In: The Lancet Oncology Jg. 20 (2019) Nr. 10, S. 1454 - 1466
    ISSN: 1470-2045; 1474-5488
  • Park, Keunchil; Bennouna, Jaafar; Boyer, Michael; Hida, Toyoaki; Hirsh, Vera; Kato, Terufumi; Lu, Shun; Mok, Tony; Nakagawa, Kazuhiko; O'Byrne, Kenneth; Paz-Ares, Luis; Schuler, Martin; Sibilot, Denis Moro; Tan, Eng-Huat; Tanaka, Hiroshi; Wu, Yi-Long; Yang, James C.-H.; Zhang, Li; Zhou, Caicun; Märten, Angela; Tang, Wenbo; Yamamoto, Nobuyuki
    Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer
    In: Lung Cancer Jg. 132 (2019) S. 126 - 131
    ISSN: 1872-8332; 0169-5002
  • Pastille, Eva; Wasmer, Marie-Hélène; Adamczyk, Alexandra; Vu, Vivian P.; Mager, Lukas F.; Phuong, Nhi Ngo Thi; Palmieri, Vittoria; Simillion, Cedric; Hansen, Wiebke; Kasper, Stefan; Schuler, Martin; Muggli, Beat; McCoy, Kathy D.; Buer, Jan; Zlobec, Inti; Westendorf, Astrid; Krebs, Philippe
    The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
    In: Mucosal Immunology Jg. 12 (2019) Nr. 4, S. 990 - 1003
    ISSN: 1935-3456; 1933-0219
  • Sahin, Ugur; Tureci, Özlem; Manikhas, Georgy M.; Lordick, Florian; Rusyn, Andriy; Vynnychenko, Ihor; Dudov, Assen; Bazin, Igor; Bondarenko, Igor; Melichar, Bohuslav; Dhaene, Karl; Wiechen, Kai; Maurus, Daniel; Schuler, Martin; Al-Batran, Salah-Eddin
    Zolbetuximab combined with EOX as first-line therapy in advanced CLDN18.2+ gastric (G) and gastroesophageal junction (GEJ) adenocarcinoma : Updated results from the FAST trial.
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 4_Suppl, S. 16
    ISSN: 0732-183X; 1527-7755
  • Tamiya, A.; Märten, A.; Popat, S.; Yamamoto, N.; Yang, J.C-H.; Hirsh, V.; Wu, Y-L.; Schuler, Martin; O'Byrne, K.
    143PD Competing central nervous system or systemic progression analysis for patients with EGFR mutation-positive NSCLC receiving afatinib in LUX-Lung 3, 6, and 7
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. 4, S. S84 - S85
    ISSN: 1556-1380; 1556-0864
  • Sahin, Ugur; Schuler, Martin; Richly, Heike; Bauer, Stefan; Krilova, Anna; Dechow, Tobias; Jerling, Markus; Utsch, Magdalena; Rohde, Christoph; Dhaene, Karl; Huber, Christoph; Türeci, Özlem
    A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
    In: European Journal of Cancer Jg. 100 (2018) S. 17 - 26
    ISSN: 0964-1947; 0959-8049
  • Wu, Yi-Long; Sequist, Lecia V.; Tan, Eng-Huat; Geater, Sarayut L.; Orlov, Sergey; Zhang, Li; Lee, Ki Hyeong; Tsai, Chun-Ming; Kato, Terufumi; Barrios, Carlos H.; Schuler, Martin; Hirsh, Vera; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Boyer, Michael; Mok, Tony; Peil, Barbara; Märten, Angela; Chih-Hsin Yang, James; Paz-Ares, Luis; Park, Keunchil
    Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non–Small-Cell Lung Cancer : Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e465 - e479
    ISSN: 1938-0690; 1525-7304
  • Zaun, Gregor; Schuler, Martin; Herrmann, Ken; Tannapfel, Andrea
    CUP syndrome : Metastatic malignancy with unknown primary tumor
    In: Deutsches Ärzteblatt international Jg. 115 (2018) Nr. 10, S. 157 - 162
    ISSN: 1866-0452
  • Yang, J.C.-.; Wu, Y.; Hirsh, V.; O’Byrne, K.; Yamamoto, N.; Popat, S.; Tamiya, A.; Kaen, D.; Märten, A.; Schuler, Martin
    Competing CNS or Systemic Progression Analysis for EGFR Mutation-Positive NSCLC Patients on Afatinib in LUX-Lung 3, 6, and 7
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. 9, Suppl., S. 163
    ISSN: 1556-1380
  • Yang, J. C.; Wu, Y.; Hirsh, V.; O'Byrne, K.; Yamamoto, N.; Popat, S.; Tamiya, A.; Kaen, D.; Marten, A.; Schuler, Martin
    Competing CNS or Systemic Progression Analysis for EGFR Mutation-Positive NSCLC Patients on Afatinib in LUX-Lung 3, 6, and 7
    In: Journal of Thoracic Surgery Jg. 13 (2018) Nr. Suppl. 9, S. 163
    ISSN: 1556-0864; 1556-1380
  • Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin
    Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)
    In: Journal of Clinical Oncology Jg. 36 (2018) Nr. 15 Suppl., S. e15121
    ISSN: 0732-183X; 1527-7755
  • Wu, Yi-Long; Hirsh, Vera; Sequist, Lecia V.; Hu, Cheng-Ping; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Schuler, Martin; Mok, Tony; Yamamoto, Nobuyuki; O’Byrne, Kenneth; Geater, Sarayut L.; Zhou, Caicun; Massey, Dan; Märten, Angela; Lungershausen, Juliane; Yang, James Chih-Hsin
    Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6)
    In: The Patient Jg. 11 (2018) Nr. 1, S. 131 - 141
    ISSN: 1178-1653; 1178-1661
  • Hamacher, Rainer; Kämpfe, Dietrich; Reuter-Jessen, Kirsten; Pöttgen, Christoph; Podleska, Lars; Farzaliyev, Farhad; Steinau, Hans-Ulrich; Schuler, Martin; Schildhaus, Hans-Ulrich; Bauer, Sebastian
    Dramatic response of a PD-L1- positive advanced angiosarcoma of the scalp to pembrolizumab
    In: JCO Precision Oncology Jg. 2 (2018)
    ISSN: 2473-4284
  • Cappuzzo, Federico; Soo, Ross; Hochmair, Maximilian; Schuler, Martin; Lam, Kwok Chi; Stehle, Gerd; Cseh, Agnieszka; Lorence, Robert M; Linden, Stephan; Forman, Nicole D; Hilbe, Wolfgang; Jazieh, Abdul Rahman; Tsai, Chun-Ming
    Global named patient use program of afatinib in advanced non-small-cell lung carcinoma patients who progressed following prior therapies
    In: Future Oncology Jg. 14 (2018) Nr. 15, S. 1477 - 1486
    ISSN: 1479-6694; 1744-8301
  • Gautschi, O.; Drilon, A.; Milia, J.; Lusque, A.; Mhanna, L.; Li, B.; Sabari, J.; Cortot, A.; Besse, B.; Mezquita, L.; Solomon, B.; Thai, A.; Couraud, S.; Veilion, R.; Mascaux, C.; Barlesi, F.; Van den Heuvel, M.; Schouten, R.; Wakelee, H.; Mah, A.; Camidge, D. R.; Ng, T.; Peled, N.; Lilach, Y.; Popat, S.; Ou, S.; Zhu, V.; Velcheti, V.; Fontecedro, A. C.; Akhoundova, D.; Fruh, M.; Zalcman, G.; Gounant, V.; Novello, S.; Bironzo, P.; Felip, E.; Martinez-Marti, A.; Moro-Sibilot, D.; Rosell, R.; Karachaliou, N.; Schuler, Martin; Wiesweg, Marcel; Diebold, J.; Mazieres, J.
    Immunotherapy for Non-Small Cell Lung Cancers (NSCLC) with Oncogenic Driver Mutations : New Results from the Global IMMUNOTARGET Registry
    In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. Suppl. 10, S. 367
    ISSN: 1556-1380; 1556-0864
  • Nadjm, S.; Pöttgen, Christoph; Gauler, Thomas; Exner, J. P.; Krebs, B.; Cheufou, D.; Umutlu, Lale; Deuschl, C.; Darwiche, Kaid; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Investigations of Long-term Survivors with locally advanced NSCLC on Morbidity of curative Therapy - Analysis of neurocognitive Effects
    In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl. 1, S. 110
    ISSN: 0179-7158; 1439-099X
  • Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel
    MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463
    ISSN: 1938-0690; 1525-7304
  • Reis, Henning; van der Vos, Kristan E.; Niedworok, Christian; Herold, Thomas; Módos, Orsolya; Szendroi, Attila; Hager, Thomas; Ingenwerth, Marc; Vis, Daniël J.; Behrendt, Mark A.; de Jong, Jeroen; van der Heijden, Michiel S.; Peyronnet, Benoit; Mathieu, Romain; Wiesweg, Marcel; Ablat, Jason; Okon, Krzysztof; Tolkach, Yuri; Keresztes, David; Nagy, Nikolett; Bremmer, Felix; Gaisa, Nadine T.; Chlosta, Piotr; Kriegsmann, Joerg; Kovalszky, Ilona; Timar, József; Kristiansen, Glen; Radzun, Heinz-Joachim; Knüchel, Ruth; Schuler, Martin; Black, Peter C.; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; van Rhijn, Bas W.G.; Nyirády, Péter; Szarvas, Tibor
    Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas
    In: International Journal of Cancer Jg. 143 (2018) Nr. 7, S. 1764 - 1773
    ISSN: 0020-7136; 1097-0215
  • Tewes, Mitra; Rettler, Teresa Maria; Beckmann, Mingo; Scheer, Karin; Ritterbusch, Ulrike; Schuler, Martin; Hense, Jörg
    Patient-Reported-Outcome-Messung (PROM) psychosozialer Belastung und Symptome für ambulante Patienten unter kurativer oder palliativer Tumortherapie : eine retrospektive Analyse eines Comprehensive Cancer Center
    In: Der Onkologe Jg. 24 (2018) Nr. 1, S. 69 - 75
    ISSN: 1433-0415; 0947-8965
  • Rodon, Jordi; Pérez-Fidalgo, Alejandro; Krop, Ian E.; Burris, Howard; Guerrero-Zotano, Angel; Britten, Carolyn D.; Becerra, Carlos; Schellens, Jan; Richards, Donald A.; Schuler, Martin; Abu-Khalaf, Maysa; Johnson, Faye M.; Ranson, Malcolm; Edenfield, Jeff; Silva, Antonio P.; Hackl, Wolfgang; Quadt, Cornelia; Demanse, David; Duval, Vincent; Baselga, Jose
    Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer
    In: Cancer Chemotherapy and Pharmacology Jg. 82 (2018) Nr. 2, S. 285 - 298
    ISSN: 0344-5704; 1432-0843
  • Juric, Dejan; Rodon, Jordi; Tabernero, Josep; Janku, Filip; Burris, Howard A.; Schellens, Jan H.M.; Middleton, Mark R.; Berlin, Jordan; Schuler, Martin; Marta, Gil-Martin; Rugo, Hope S.; Ruth, Seggewiss-Bernhardt; Huang, Alan; Bootle, Douglas; Demanse, David; Blumenstein, Lars; Coughlin, Christina; Quadt, Cornelia; Baselga, José
    Phosphatidylinositol 3-kinase a–selective inhibition with alpelisib (BYL719) in PIK3CA-altered solid tumors : Results from the first-in-human study
    In: Journal of Clinical Oncology Jg. 36 (2018) Nr. 13, S. 1291 - 1299
    ISSN: 0732-183X; 1527-7755
  • Wiesweg, Marcel; Reis, Henning; Köster, Tobias; Goetz, Moritz; Worm, Karl; Herold, Thomas; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Markus, Peter; Virchow, Isabel; Kostbade, Karina; Wolf, Nathalie; Zaun, Gregor; Metzenmacher, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer
    In: Clinical Colorectal Cancer Jg. 17 (2018) Nr. 2, S. e331 - e352
    ISSN: 1938-0674; 1533-0028
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 Study
    In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl.1, S. S41 - S42
    ISSN: 0179-7158; 1439-099X
  • Tewes, Mitra; Rettler, Teresa; Wolf, Nathalie; Hense, Jörg; Schuler, Martin; Teufel, Martin; Beckmann, Mingo
    Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer center
    In: Supportive Care in Cancer Jg. 26 (2018) Nr. 10, S. 3641 - 3647
    ISSN: 1433-7339; 0941-4355
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Cheufou, D.; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trial
    In: Radiotherapy and Oncology Jg. 127 (2018) Nr. Suppl.1, S. S253 - S254
    ISSN: 0167-8140; 1879-0887
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Worm, Karl; Christoph, Daniel; Wiesweg, Marcel; Freitag, Lutz; Schmid, Kurt Werner; Theegarten, Dirk; Hager, Thomas; Koenig, Michael J.; He, Kai; Taube, Christian; Schuler, Martin; Breitenbücher, Frank
    Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    In: Clinical Lung Cancer Jg. 19 (2018) Nr. 6, S. e879 - e884
    ISSN: 1938-0690; 1525-7304
  • Sayehli, Cyrus; Nogova, Lucia; Nogai, Hendrik; Park, Se Hoon; Richly, Heike; Cathomas, Richard; Wermke, Martin; Bender, Sebastian; Navarro, Alejandra; Schostak, Martin; Grande, Enrique; Cassier, Philippe; Janitzky, Andreas; Penel, Nicolas; Ellinghaus, Peter; Tai, David Wai-Meng; Gillessen, Silke; Grüllich, Carsten; Joerger, Markus; Schuler, Martin
    Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression.
    In: Journal of Clinical Oncology Jg. 36 (2018) Nr. 6 Suppl., S. 494
    ISSN: 0732-183X; 1527-7755
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gauler, Thomas; Guberina, M.; Darwiche, Kaid; Aigner, Clemens; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin
    Sequential Dose Escalation Study NEOAHA for locally advanced NSCLC - Phase I-Results of Stage 1 (Integrated Boost-Radiation in neoadjuvant Therapy)
    In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl. 1, S. S23 - S24
    ISSN: 0179-7158; 1439-099X
  • Joerger, M.; Soo, R. A.; Cho, B. C.; Navarro, A.; Sayehli, C. M.; Richly, Heike; Tai, D.; Kim, D. W.; Wolf, J.; Cassier, P.; Bender, S.; Ellinghaus, P.; Ince, S.; Rajagopalan, P.; Ocker, M.; Schuler, Martin
    A novel mRNA-based patient selection strategy identifies fibroblast growth factor receptor (FGFR) inhibitor-sensitive tumors : Results from rogaratinib Phase-1 study
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
    ISSN: 0923-7534; 1569-8041
  • Van Geel, Robin M. J. M.; Tabernero, Josep; Elez, Elena; Bendell, Johanna C.; Spreafico, Anna; Schuler, Martin; Yoshino, Takayuki; Delord, Jean-Pierre; Yamada, Yasuhide; Lolkema, Martijn P.; Faris, Jason E.; Eskens, Ferry A. L. M.; Sharma, Sunil; Yaeger, Rona; Lenz, Heinz-Josef; Wainberg, Zev A.; Avsar, Emin; Chatterjee, Arkendu; Jaeger, Savina; Tan, Eugene; Maharry, Kati; Demuth, Tim; Schellens, Jan H. M.
    A phase Ib dose-escalation study of encorafenib and cetuximab with or without alpelisib in metastatic BRAF-mutant colorectal cancer
    In: Cancer Discovery Jg. 7 (2017) Nr. 6, S. 610 - 619
    ISSN: 2159-8274; 2159-8290
  • Schadendorf, Dirk; Schuler, Martin
    Checkpointinhibitoren
    In: Der Onkologe Jg. 23 (2017) Nr. 8, S. 619 - 625
    ISSN: 1433-0415; 0947-8965
  • Breitenbücher, Frank; Von Pawel, Joachim; Sebastian, Martin; Kortsik, Cornelius; Ting, Saskia; Kasper, Stefan; Wohlschläger, Jeremias; Worm, Karl; Morresi-Hauf, Alicia; Schad, Arno; Westerwick, Daniela; Wehler, Beatrice; Werner, Martin; Munzert, Gerd; Gaschler-Markefski, Birgit; Schmid, Kurt Werner; Schuler, Martin
    Comprehensive biomarker analyses in patients with advanced or metastatic non-small cell lung cancer prospectively treated with the polo-like Kinase 1 Inhibitor BI2536
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. 7-8, S. 435 - 439
    ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240
  • Wieczorek, Sarah A.; Breitenbücher, Frank; Soni, Aashish; Paul-Konietzko, Katja; Ziegler, Sophie; Sak, Ali; Iliakis, George; Schuler, Martin
    Deregulated BCL-2 family proteins impact on repair of DNA double-strand breaks and are targets to overcome radioresistance in lung cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 9, S. 1733 - 1744
    ISSN: 0171-5216
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K.; Folprecht, G.; Probst, S.; Thuss-Patience, P.; Trojan, J.; Koenigsmann, M.; Lindig, U.; Pohl, M.; Kasper, Stefan; Hler, M. M.; Goetze, T.; Schuler, Martin; Jaeger, E.; Hofheinz, R. D.
    Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer : Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)
    In: Annals of Oncology Jg. 28 5 (2017) -
    ISSN: 0923-7534; 1569-8041
  • Wu, Yi-Long; Sequist, Lecia V; Hu, Cheng-Ping; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Li, Wei; Hou, Mei; Schuler, Martin; Mok, Tony; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Gibson, Neil; Massey, Dan; Kim, Miyoung; Yang, James Chih-Hsin
    EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients : analysis of LUX-Lung 3 and 6
    In: The British Journal of Cancer: BJC Jg. 116 (2017) Nr. 2, S. 175 - 185
    ISSN: 1532-1827; 0007-0920
  • Nogova, Lucia; Sequist, Lecia V.; Garcia, Jose Manuel Perez; Andre, Fabrice; Delord, Jean-Pierre; Hidalgo, Manuel; Schellens, Jan H.M.; Cassier, Philippe A.; Camidge, D. Ross; Schuler, Martin; Vaishampayan, Ulka; Burris, Howard; Tian, G. Gary; Campone, Mario; Wainberg, Zev A.; Lim, Wan-Teck; LoRusso, Patricia; Shapiro, Geoffrey I.; Parker, Katie; Chen, Xueying; Choudhury, Somesh; Ringeisen, Francois; Graus-Porta, Diana; Porter, Dale; Isaacs, Randi; Buettner, Reinhard; Wolf, Jürgen
    Evaluation of BGJ398, a Fibroblast growth factor receptor 1-3 kinase inhibitor, in patientswith advanced solid tumors harboring genetic alterations in fibroblast growth factor receptors : Results of a global phase I, dose-escalation and dose-expansion study
    In: Journal of Clinical Oncology Jg. 35 (2017) Nr. 2, S. 157 - 165
    ISSN: 0732-183X; 1527-7755
  • Tureci, Özlem; Wiechen, Kai; Bazin, Igor; Maurus, Daniel; Schuler, Martin; Zvirbule, Zanete; Sahin, Ugur; Dhaene, Karl; Al-Batran, Salah-Eddin; Vynnychenko, Ihor; Melichar, Bohuslav; Rusyn, Andriy V.; Manikhas, Georgy; Dudov, Assen; Lordick, Florian
    Expression of Claudin 18.2 and HER2 in gastric, gastroesophageal junction, and esophageal cancers : Results from the FAST study
    In: Journal of Clinical Oncology Jg. 35 (2017) S. 4038 - 4038
    ISSN: 0732-183X; 1527-7755
  • Schuler, Martin; Paz-Ares, L.; Sequist, L. V.; Tan, E. H.; Mok, T.; Hirsh, V.; O'Byrne, K.; Zhang, Lihua; Yamamoto, N.; Boyer, M.; Shah, R.; Bennouna, J.; Dickgreber, N. J.; De Greve, J.; Love, J.; Marten, A.; Fan, J.; Ehrnrooth, E.; Park, K.; Yang, JCH
    First-line afatinib for advanced EGFR mutation-positive (EGFRm plus ) NSCLC : analysis of long-term responders in the Phase III LUX-Lung 3, 6 and 7 trials
    In: Eur J Cancer Jg. 72 1 (2017) S. 176 - S177
    ISSN: 0959-8049
  • Schuler, Martin; Paz-Ares, L.; Sequist, L. V.; Wu, Y. L.; Geater, S. L.; Marten, A.; Fandrey, Joachim; Park, K.; Yang, JCH
    First-line afatinib for advanced EGFRm1 NSCLC : Analysis of long-term responders (LTRs) in the LUX-Lung (LL) 3, 6 and 7 trials
    In: Ann Oncol Jg. 28 2 (2017) -
    ISSN: 0923-7534; 1569-8041
  • Schuler, Martin; Paz-Ares, L.; Sequist, L. V.; Sebastian, M.; Wu, Y. L.; Geater, S. L.; Marten, A.; Fan, J.; Park, K.; Yang, JCH
    First-line afatinib in patients with EGFR mutation-positive (EGFRm+) non-small-cell lung cancer (NSCLC) : analysis of long-term responders (LTRs) in the LUX-Lung 3, 6 and 7 trials
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 172
    ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240
  • Hochmair, M.; Cappuzzo, F.; Tsai, C. M.; Schuler, Martin; Lam, K. C.; Stehle, G.; Cseh, A.; Lorence, R. M.; Linden, S.; Carriere, P.; Soo, R.
    Global named patient use (NPU) program of afatinib in heavily pretreated advanced NSCLC patients who progressed following prior therapies, including erlotinib or gefitinib
    In: Eur J Cancer Jg. 72 1 (2017) S. 183 - S184
    ISSN: 0959-8049
  • Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Heinzelmann, F.; Cheufou, D.; Kimmich, M.; Friedel, G.; Schmidberger, H.; Darwiche, Kaid; Jendrossek, Verena; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph
    Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trial
    In: Annals of Oncology Jg. 28 (2017) Nr. 5, S. 1084 - 1089
    ISSN: 1569-8041; 0923-7534
  • Tewes, Mitra; Peis, Michael Wilhelm; Bogner, Simon; Theysohn, Jens; Reinboldt, Marcus Paul; Schuler, Martin; Welt, Anja
    Hepatic arterial infusion chemotherapy for extensive liver metastases of breast cancer : efficacy, safety and prognostic parameters
    In: Journal of Cancer Research and Clinical Oncology Jg. 143 (2017) Nr. 10, S. 2131 - 2141
    ISSN: 0171-5216; 0171-5216
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, S. 54 - 64
    ISSN: 1556-1380; 1556-0864
  • Okimoto, Ross A; Breitenbücher, Frank; Olivas, Victor R; Wu, Wei; Gini, Beatrice; Hofree, Matan; Asthana, Saurabh; Hrustanovic, Gorjan; Flanagan, Jennifer; Tulpule, Asmin; Blakely, Collin M; Haringsma, Henry J; Simmons, Andrew D; Gowen, Kyle; Suh, James; Miller, Vincent A; Ali, Siraj; Schuler, Martin; Bivona, Trever G.
    Inactivation of Capicua drives cancer metastasis
    In: Nature Genetics Jg. 49 (2017) Nr. 1, S. 87 - 96
    ISSN: 1061-4036; 1546-1718
  • Thress, Kenneth S.; Jacobs, Vivien; Angell, Helen K.; Yang, James Chih-Hsin; Sequist, Lecia V.; Blackhall, Fiona; Su, Wu-Chou; Schuler, Martin; Wolf, Jürgen; Gold, Kathryn A.; Cantarini, Mireille; Barrett, J. Carl; Jänne, Pasi A.
    Modulation of Biomarker Expression by Osimertinib : Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 10, S. 1588 - 1594
    ISSN: 1556-1380; 1556-0864
  • Kasper, Stefan; Reis, Henning; Ziegler, Sophie; Nothdurft, Silke; Mueller, Andre; Goetz, Moritz; Wiesweg, Marcel; Phasue, Jeannette; Ting, Saskia; Wieczorek, Sarah; Even, Anna; Worm, Karl; Pogorzelski, Michael; Breitenbuecher, Sandra; Meiler, Johannes; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Breitenbücher, Frank; Schuler, Martin
    Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy
    In: OncoTarget Jg. 8 (2017) Nr. 28, S. 45898 - 45917
    ISSN: 1949-2553
  • Al-Batran, S. E.; Pauligk, C.; Homann, N.; Schmalenberg, H.; Kopp, H. G.; Haag, G. M.; Luley, K. B.; Schmiegel, W.; Folprecht, G.; Probst, S.; Prasnikar, N.; Thuss-Patience, P.; Fischbach, W.; Trojan, J.; Koenigsmann, M.; Goetze, T. O.; Kraus, T. W.; Battmann, A.; Moenig, S. P.; Bechstein, W.; Gaiser, T.; Tannapfel, A.; Jäger, E.; Schuler, Martin; Lindig, U.; Pohl, M.; Kasper, Stefan; Möhler, M.; Hofheinz, R. D.
    Perioperative chemotherapy with docetaxel, oxaliplatin and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO) : a rando
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 200 - 201
    ISSN: 2296-5270; 2321-3575
  • Al-Batran, Salah-Eddin; Homann, Nils; Schmalenberg, Harald; Kopp, Hans-Georg; Haag, Georg Martin; Luley, Kim Barbara; Schmiegel, Wolff H.; Folprecht, Gunnar; Probst, Stephan; Prasnikar, Nicole; Thuss-Patience, Peter C.; Fischbach, Wolfgang; Trojan, Jorg; Koenigsmann, Michael; Pauligk, Claudia; Goetze, Thorsten Oliver; Jaeger, Elke; Meiler, Johannes; Schuler, Martin; Hofheinz, Ralf
    Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.
    In: Journal of Clinical Oncology Jg. 35 (2017) Nr. 15_suppl, S. 4004
    ISSN: 0732-183X; 1527-7755
  • Schuler, Martin; Chan, S. L.; Yen, C.; Lin, C.; Choo, S. P.; Weiss, K.; Geier, A.; Okusaka, T.; Lim, H. Y.; Macarulla, T.; Zhu, A. X.; Kakizume, T.; Gu, Y.; Porta, D. G.; Myers, A. P.; Delord, J.
    Phase I/II study of FGF401 in adult patients (pts) with hepatocellular carcinoma (HCC) or solid tumors and positive FGFR4/KLB expression
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3, S. 234 - 235
    ISSN: 2296-5270; 1538-7445
  • Sebastian, M.; Schuler, Martin; Schulz, C.; Deschler-Baier, B.; Kimmich, M.; Hilgert-Daute, K.; Griesinger, F.
    Randomised Phase III study of osimertinib vs platinum-pemetrexed for EGFR T790M-positive advanced NSCLC (AURA3)
    In: Oncology Research and Treatment Jg. 40 (2017) Nr. Suppl. 3: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts, S. 170
    ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Christoph, Daniel; Worm, Karl; Freitag, Lutz; Schmid, Kurt Werner; Hager, Thomas; Breitenbücher, Frank; Schuler, Martin
    Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung Adenocarcinoma
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S1201 - S1201
    ISSN: 1556-1380; 1556-0864
  • Scheulen, Max Ernst; Kaempgen, Eckhart; Keilholz, Ulrich; Heinzerling, Lucie; Ochsenreither, Sebastian; Abendroth, Annalena; Huger, Ralf A.; Grubert, Matthias; Wetter, Axel; Guberina, Nika; Bauer, Sebastian; Schuler, Gerold; Bornfeld, Norbert; Schuler, Martin; Richly, Heike
    STREAM : A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (5) treatment of chemonaive patients (pts) with metastatic uveal melanoma (MUM)
    In: Journal of Clinical Oncology Jg. 35 (2017) Nr. 15, S. 9511
    ISSN: 0732-183X; 1527-7755
  • Kalkavan, Halime; Sharma, Piyush; Kasper, Stefan; Helfrich, Iris; Pandyra, Aleksandra A.; Gassa, Asmae; Virchow, Isabel; Flatz, Lukas; Brandenburg, Tim; Namineni, Sukumar; Heikenwalder, Mathias; Höchst, Bastian; Knolle, Percy A.; Wollmann, Guido; Von Laer, Dorothee; Drexler, Ingo; Rathbun, Jessica; Cannon, Paula M.; Scheu, Stefanie; Bauer, Jens; Chauhan, Jagat; Häussinger, Dieter; Willimsky, Gerald; Löhning, Max; Schadendorf, Dirk; Brandau, Sven; Schuler, Martin; Lang, Philipp A.; Lang, Karl S.
    Spatiotemporally restricted arenavirus replication induces immune surveillance and type i interferon-dependent tumour regression
    In: Nature Communications Jg. 8 (2017) S. 14447
    ISSN: 2041-1723
  • Sequist, L.; Wu, Y. L.; Schuler, Martin; Kato, T.; Yang, JCH; Tanaka, H.; Hida, T.; Lu, S.; Park, K.; Laurie, S.; Bennouna, J.; Sibilot, D. M.; Marten, A.; Peil, B.; Ehrnrooth, E.; Yamamoto, N.; Nakagawa, K.
    Subsequent therapies post-afatinib among patients (pts) with EGFR mutation-positive (EGFRm plus ) NSCLC in LUX-Lung (LL) 3, 6 and 7
    In: Ann Oncol Jg. 28 5 (2017) -
    ISSN: 0923-7534; 1569-8041
  • Cappuzzo, Federico; Soo, Ross Andrew; Hochmair, Maximilian Johannes; Schuler, Martin; Mok, Tony Shu Kam; Stehle, Gerd; Cseh, Agnieszka; Lorence, Robert M..; Linden, Stephan; Forman, Nicole D.; Tsai, Chunming
    1236P - Global named patient use (NPU) program of afatinib, an oral ErbB family blocker, in heavily pretreated advanced non-small cell lung carcinoma (NSCLC) patients who progressed following prior therapies, including erlotinib or gefitinib (E/G)
    In: Annals of Oncology Jg. 27 (2016) Nr. Supplement 6, S. vi427
    ISSN: 1569-8041; 0923-7534
  • Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Jürgen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Sutradhar, Santosh; Li, Siyu; Szczudlo, Tomasz; Yovine, Alejandro; Shaw, Alice T
    Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1) : updated results from the multicentre, open-label, phase 1 trial
    In: The Lancet Oncology Jg. 17 (2016) Nr. 4, S. 452 - 463
    ISSN: 1470-2045; 1474-5488
  • Fein, Luis; Wu, Yi-Long; Sequist, Lecia V; Geater, Sarayut L; Orlov, Sergey; Lee, Ki Hyeong; Tsai, Chun-Ming; Kato, Terufumi; Kiura, Katsuyuki; Barrios, Carlos H; Schuler, Martin; Hirsh, Vera; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Mok, Tony; Massey, Dan; Märten, Angela; Chih-Hsin Yang, James
    Afatinib Versus Chemotherapy for EGFR Mutation-Positive NSCLC Patients Aged >=65 Years : Subgroup Analysis of LUX-Lung 3/6: P1.33: Track: Advanced NSCLC
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 10 Supplement, S. 202 - S.203
    ISSN: 1556-1380; 1556-0864
  • Yang, J C-H; Park, K; Kim, J-H; Bennouna, J; Chen, Y-M; Chouaid, C; De Marinis, F; Feng, J-F; Grossi, F; Kim, D-W; Liu, X; Lu, S; Strausz, J; Vinnyk, Y; Wiewrodt, R; Zhou, C; Wang, B; Chand, V K; Planchard, D; Ignatius Ou, Sai Hong; Planchard, David; Park, Keunchil; Schuler, Martin; Yang, James; Chand, Vikram; Rohr, Klaus; Bagnes, Claudia; Martin, Claudio Marcelo; Recondo, Gonzalo; Zarba, Juan Jose; Blajman, Cesar; Richardet, Martín; McLachlan, Sue-Anne; Parente, Phillip; Underhill, Craig; Crombie, Catherine; Mainwaring, Paul; Greil, Richard; Humblet, Yves; Bustin, Frédérique; Carestia, Luciano; Galdermans, Danny; Lambrechts, Marc; Delval, Laetitia; Vercauter, Piet; Zhou, Caicun; Wang, Jin; Huang, Cheng; Lin, Xiaoyan; Wu, Yilong; Liu, Xiaoqing; Cheng, Ying; Qin, Shukui; Feng, Jifeng; Huang, Jianjin; Zhang, Yiping; Lu, Shun; Zereu, Manuela; Garicochea, Bernardo; Zadra, Cyntia Albuquerque; Riska, Henrik; Alanko, Tuomo; Cadranel, Jacques; Chouaid, Christos; Zalcman, Gérard; Sibilot, Denis Moro; Perol, Maurice; Planchard, David; Bennouna, Jaafar; Fournel, Pierre; Gervais, Radj; Rotarski, Maciej; Coudert, Bruno; Schuler, Martin; Thomas, Michael; Wehler, Thomas; Faehling, Martin; Keilholz, Ulrich; Laack, Eckart; von Pawel, Joachim; Huber, Rudolf; Dickgreber, Nicolas; Wiewrodt, Rainer; Mark, Zsuzsanna; Tehenes, Sandor; Strausz, Janos; Sarosi, Veronika; Prabhash, Kumar; Jain, Minish; Venkatesan, Srinivasan; Sharma, Lalit; Dadhich, Hemant; Nagarkar, Rajnish Vasant; Onn, Amir; Gottfried, Maya; Stemmer, Solomon; Migliorino, Maria Rita; Grossi, Francesco; Bidoli, Paolo; Bearz, Alessandra; Gridelli, Cesare; Milandri, Carlo; Platania, Marco; Ceresoli, Giovanni Luca; Cruciani, Giorgio; Delgado, Francisco Gutierrez; Gonzalez Perez, José Luis; Luna, Gabriela Alvarado; Baca, Othon Padilla; Aerts, J G J V; Stigt, J A; Dingemans, A M C; Herder, G J M; Gans, S J M; Salas Sánchez, Jorge Fernando; Alvarez Barreda, Renzo Luzgardo; Pantigoso, Wilbert Rodriguez; Palomino, Osbert Luis Mejia; Jaskiewicz, Piotr; Kazarnowicz, Andrzej; Serwatowski, Piotr; Szczesna, Aleksandra; Jassem, Jacek; Lubennikov, Vladimir; Karaseva, Nina; Orlov, Sergey; Ragulin, Yuri; Garrido, Pilar; González Larriba, José Luis; Camps, Carlos; Campelo, Rosario García; Lianes, Pilar; Cobo, Manuel; Felip, Enriqueta; Kim, Dong-Wan; Kim, Sang-We; Park, Keunchil; Kim, Joo-Hang; Han, Ji-Youn; Kim, Young-Chul; Yang, Chih-Hsin; Hsia, Te-Chun; Chen, Yuh-Min; Tsai, Ying-Huang; Chang, Gee-Chen; Tsao, Thomas Chang-Yao; Su, Wu-Chou; Huang, Ming-Shyan; Ho, Ching-Liang; Hsieh, Ruey-Kuen; Vinnyk, Yuriy; Popovych, Oleksandr; Ponomarova, Olga; Bondarenko, Igor; Polishchuk, Iryna; Shah, Riyaz; Mitra, Sanka; Popat, Sanjaykumar; Spicer, James; Toy, Elizabeth; Popat, Sanjaykumar; Talbot, Toby; Brown, Emma; Upadhyay, Sunil; Summers, Yvonne; Gurtler, Jayne; Meza, Luis; Thropay, John
    Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib : phase III randomized LUX-Lung 5 trial
    In: Annals of Oncology Jg. 27 (2016) Nr. 3, S. 417 - 423
    ISSN: 0923-7534; 1569-8041
  • Reimer, P.; Höhler, T.; Schuler, Martin; Markus, P.; Knipp, Heike; Schumacher, B.; Dechene, Alexander; Ting, Saskia; Kasper, S.; Meiler, Johannes; Kostbade, K.; Berger, W.; Herold, T.; Trarbach, Tanja; Linden, G.; Steinmetz, H.T.; Schmid, Kurt Werner; Worm, K.; Paul, A.
    Cetuximab biweekly (q2w) plus mFOLFOX6 as 1st line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) – Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl.6, S. 508P
    ISSN: 1569-8041; 0923-7534
  • Nel, Ivonne; Gauler, Thomas; Bublitz, Kira; Lazaridis, Lazaros; Goergens, André; Giebel, Bernd; Schuler, Martin; Hoffmann, Andreas-Claudius
    Circulating Tumor Cell Composition in Renal Cell Carcinoma
    In: PLoS ONE Jg. 11 (2016) Nr. 4, S. e0153018
    ISSN: 1932-6203
  • Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nöpel-Dünnebacke, Stefanie; Ahrens, Maike; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, Maria; Breitenbücher, Frank; Cheufou, Danjouma; Özkan, Filiz; Darwiche, Kaid; Hoiczyk, Mathias; Reis, Henning; Welter, Stefan; Eberhardt, Wilfried; Eisenacher, Martin; Teschler, Helmut; Stamatis, Georgios; Schmiegel, Wolff; Hahn, Stephan Albrecht; Baraniskin, Alexander
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    In: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805
    ISSN: 0171-5216
  • Tabernero, J.; van Geel, R.; Guren, T.; Yaeger, R.; Spreafico, A.; Faris, J.; Yoshino, T.; Yamada, Y.; Tae, W. K.; Bendell, J.; Schuler, Martin; Lenz, H. J.; Eskens, F.; Desai, J.; Hochster, H.; Avsar, E.; Demuth, T.; Sandor, V.; Elez, E.; Schellens, J.
    Combination of encorafenib and cetuximab with or without alpelisib in patients with advanced BRAF-mutant colorectal cancer (BRAFm CRC) : phase 2 results
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 2, S. ii127 - ii128
    ISSN: 0923-7534; 1569-8041
  • Stang, Andreas; Jöckel, Karl-Heinz; Kühl, Hilmar; Darwiche, Kaid; Schuler, Martin; Kowall, Bernd
    Concluding remarks : [Korrespondenz zu "Lung Cancer Screening Using Low Dose CT Scanning in Germany by Prof. Dr. med. Andreas Stang, MPH, Prof. Dr. med. Martin Schuler, Dr. rer. nat. Dr. rer. san. Bernd Kowall, Dr. med. Kaid Darwiche, PD Dr. med. Hilmar Kühl, and Prof. Dr. rer. nat. Karl-Heinz Jöckel in issue 38/2015"]
    In: Deutsches Ärzteblatt international Jg. 113 (2016) Nr. 17, S. 297 - 298
    ISSN: 1866-0452
  • Stintzing, S.; Modest, D. P.; Jung, A.; Kirchner, T.; Schafer, R.; Sers, C.; Hildebrandt, B.; Daum, S.; Folprecht, G.; Schuler, Martin; Kasper, Stefan; Trojan, J.; Jaeger, D.; Schulze-Bergkamen, H.; von Weikersthal, L. F.; Schalhorn, A.; Heinemann, V.
    Differences in gene-expression in mCRC tissue samples with regard to tumor location and used chemotherapeutic substances : Data of the FIRE-1 study
    In: Journal of Clinical Oncology Jg. 34 (2016) Nr. Suppl. 4, S. 562
    ISSN: 0732-183X; 1527-7755
  • Yang, J C-H; Sequist, L V; Zhou, C; Schuler, Martin; Geater, S L; Mok, T; Hu, C-P; Yamamoto, N; Feng, J; O'Byrne, K; Lu, S; Hirsh, V; Huang, Y; Sebastian, M; Okamoto, I; Dickgreber, N; Shah, R; Märten, A; Massey, D; Wind, S; Wu, Y-L
    Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma : post hoc analyses of the randomized LUX-Lung 3 and 6 trials
    In: Annals of Oncology Jg. 27 (2016) Nr. 11, S. 2103 - 2110
    ISSN: 0923-7534; 1569-8041
  • Schuler, Martin; Sequist, Lecia; Popat, Sanjay; Mok, Tony; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Wu, Yi-Long
    First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 3, S. 380 - 390
    ISSN: 1556-1380; 1556-0864
  • Stang, Andreas; Kowall, Bernd; Schuler, Martin; Jöckel, Karl-Heinz
    Früherkennung von Lungenkrebs : Low-dose-Computertomographie-Screening
    In: Der Onkologe Jg. 22 (2016) Nr. 8, S. 568 - 577
    ISSN: 0947-8965
  • Al-Batran, Salah-Eddin; Hofheinz, Ralf D; Pauligk, Claudia; Kopp, Hans-Georg; Haag, Georg Martin; Luley, Kim Barbara; Meiler, Johannes; Homann, Nils; Lorenzen, Sylvie; Schmalenberg, Harald; Probst, Stephan; Koenigsmann, Michael; Egger, Matthias; Prasnikar, Nicole; Caca, Karel; Trojan, Jörg; Martens, Uwe M; Block, Andreas; Fischbach, Wolfgang; Mahlberg, Rolf; Clemens, Michael; Illerhaus, Gerald; Zirlik, Katja; Behringer, Dirk M; Schmiegel, Wolff; Pohl, Michael; Heike, Michael; Ronellenfitsch, Ulrich; Schuler, Martin; Bechstein, Wolf O; Königsrainer, Alfred; Gaiser, Timo; Schirmacher, Peter; Hozaeel, Wael; Reichart, Alexander; Goetze, Thorsten O; Sievert, Mark; Jäger, Elke; Mönig, Stefan; Tannapfel, Andrea
    Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO
    In: The Lancet Oncology Jg. 17 (2016) Nr. 12, S. 1697 - 1708
    ISSN: 1470-2045; 1474-5488
  • Al-Batran, S. E.; Schuler, Martin; Zvirbule, Z.; Manikhas, G.; Lordick, F.; Tureci, O.; Huber, C.; Sahin, U.
    IMAB362 : a novel immunotherapeutic antibody targeting the tight-junction protein component CLAUDIN18.2 in gastric cancer
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 2, S. ii141 - ii142
    ISSN: 0923-7534; 1569-8041
  • Barrios, Carlos H; Wu, Yi-Long; Chih-Hsin Yang, James; Sequist, Lecia V; Geater, Sarayut L; Mok, Tony; Hu, Cheng-Ping; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Lu, Shun; Hirsh, Vera; Sebastian, Martin; Okamoto, Isamu; Shah, Riyaz; Märten, Angela; Massey, Dan; Wind, Sven; Schuler, Martin
    Impact of Dose Adjustment on Afatinib Safety and Efficacy in EGFR Mutation-Positive NSCLC: Post-Hoc Analyses of LUX-Lung 3/6: Track: Advanced NSCLC
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 10 Supplement, S. 210 - S. 211
    ISSN: 1556-1380; 1556-0864
  • Schuler, Martin; Yang, J; Sequist, L V; Yamamoto, N; Zhou, C; O'Byrne, K; Hirsh, V; Mok, T; Shah, R; Wu, Y-L
    Impact of dose adjustment on the safety and efficacy of afatinib in patients (pts) with advanced EGFR mutation-positive non-small cell lung cancer (NSCLC): Post-hoc analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6) : 138PD
    In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. Suppl. 4, S. 116 - 117
    ISSN: 1556-1380; 1556-0864
  • Falkenhorst, Johanna; Grunewald, Susanne; Mühlenberg, Thomas; Marino-Enriquez, Adrian; Reis, Anna-Carina; Corless, Christopher; Heinrich, Michael; Treckmann, Jürgen Walter; Podleska, Lars; Schuler, Martin; Fletcher, Jonathan Alfred; Bauer, Sebastian
    Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinib
    In: OncoTarget Jg. 7 (2016) Nr. 27, S. 41390 - 41403
    ISSN: 1949-2553
  • Schuler, Martin; Yang, J. C.-H.; Planchard, D.
    Reply to the letter to the editor ‘What is the clinical impact of the LUX-Lung 5 trial?’ by Addeo
    In: Annals of Oncology Jg. 27 (2016) Nr. 6, S. 1172 - 1173
    ISSN: 0923-7534; 1569-8041
  • Hoya, V.; Stuschke, Martin; Sauerwein, Wolfgang; Bornfeld, Norbert; Metz, Klaus; Schuler, Martin; Kasper, Stefan
    Small cell neuroendocrine carcinoma of the right eye : A case report
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 189 - 189
    ISSN: 2296-5270
  • Joerger, M.; Soo, R.; Cho, B.C.; Mendivil, A. Navarro; Sayehli, C.; Richly, Heike; Tai, D.; Kim, D.-W.; Wolf, J.; Cassier, P.; Ellinghaus, P.; Hildebrandt, S.; Behre, S.; Helmbrecht, C.; Kerpen, S.; Zielinski, D.; Ince, S.; Rajagopalan, P.; Ocker, M.; Schuler, Martin
    developmental therapeuticsPhase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels
    In: Annals of Oncology Jg. 27 (2016) Nr. Suppl. 6, 360O_PR
    ISSN: 1569-8041; 1569-8041
  • Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, Eleni; Freitag, Lutz; Lübcke, Wolfgang; Welter, Stefan; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Stamatis, Georgios; Stuschke, Martin
    Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy
    In: Journal of Thoracic Disease Jg. 7 (2015) Nr. 3, S. 264 - 272
    ISSN: 2072-1439
  • Schuler, Martin; Yang, J. C. H.; Park, K.; Chand, V. K.; Wang, B.; Planchard, D.
    Afatinib (a) plus paclitaxel (p) following progression on a monotherapy in patients (pts) with metastatic non-small-cell lung cancer (nsclc) who previously benefited from erlotinib (e)/gefitinib (g) : a global randomised phase iii triallux-lung 5 (ll5)
    In: Annals of Oncology Jg. 26 (2015) Nr. S 1, S. i33 - i34
    ISSN: 0923-7534; 1569-8041
  • Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Orlov, Sergey; Mok, Tony; Boyer, Michael; Su, Wu-Chou; Lee, Ki Hyeong; Kato, Terufumi; Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria; Sequist, Lecia V
    Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6) : analysis of overall survival data from two randomised, phase 3 trials
    In: The Lancet Oncology Jg. 16 (2015) Nr. 2, S. 141 - 151
    ISSN: 1474-5488; 1470-2045
  • Breitenbücher, Frank; Schuler, Martin; Markova, Boyka
    Alternative tumor suppressor mechanisms in lung carcinomas - modulation of senescence by growth factor-induced signaling
    In: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. 1033
    ISSN: 0008-5472
  • Richly, Heike; Kim, Tae Min; Schuler, Martin; Kim, Dong-Wan; Harrison, Simon J.; Shaw, Alice T.; Boral, Anthony L.; Yovine, Alejandro; Solomon, Benjamin
    Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma
    In: Blood Jg. 126 (2015) Nr. 10, S. 1257 - 1258
    ISSN: 0006-4971
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, Thomas; Reimer, Peter; Steinmetz, Tilman; Berger, Winfried; Linden, Gabriele; Ting, Saskia; Markus, Peter; Paul, Andreas; Dechene, Alexander; Schumacher, Brigitte; Kosbade, Karina; Worm, Karl; Schmid, Kurt Werner; Herold, Thomas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) (exon 2) metastatic colorectal cancer (mCRC) : Primary endpoint and subgroup analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology Jg. 33 (2015) Nr. 15 Suppl., S. 3568
    ISSN: 0732-183X; 1527-7755
  • Yang, James C.-H.; Sequist, Lecia V.; Geater, Sarayut Lucien; Tsai, Chun-Ming; Mok, Tony Shu Kam; Schuler, Martin; Yamamoto, Nobuyuki; Yu, Chong-Jen; Ou, Sai-Hong I.; Zhou, Caicun; Massey, Daniel; Zazulina, Victoria; Wu, Yi-Long
    Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations : A combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
    In: The Lancet Oncology Jg. 16 (2015) Nr. 7, S. 830 - 838
    ISSN: 1474-5488
  • George, Julie; Lim, Jing Shan; Jang, Se Jin; Cun, Yupeng; Ozretia, Luka; Kong, Gu; Leenders, Frauke; Lu, Xin; Fernández-Cuesta, Lynnette; Bosco, Graziella; Müller, Christian; Dahmen, Ilona; Jahchan, Nadine S.; Park, Kwon-Sik; Yang, Dian; Karnezis, Anthony N.; Vaka, Dedeepya; Torres, Angela; Wang, Maia Segura; Korbel, Jan O.; Menon, Roopika; Chun, Sung-Min; Kim, Deokhoon; Wilkerson, Matt; Hayes, Neil; Engelmann, David; Pützer, Brigitte; Bos, Marc; Michels, Sebastian; Vlasic, Ignacija; Seidel, Danila; Pinther, Berit; Schaub, Philipp; Becker, Christian; Altmüller, Janine; Yokota, Jun; Kohno, Takashi; Iwakawa, Reika; Tsuta, Koji; Noguchi, Masayuki; Muley, Thomas; Hoffmann, Hans; Schnabel, Philipp A.; Petersen, Iver; Chen, Yuan; Soltermann, Alex; Tischler, Verena; Choi, Chang-Min; Kim, Yong-Hee; Massion, Pierre P.; Zou, Yong; Jovanovic, Dragana; Kontic, Milica; Wright, Gavin M.; Russell, Prudence A.; Solomon, Benjamin; Koch, Ina; Lindner, Michael; Muscarella, Lucia A.; La Torre, Annamaria; Field, John K.; Jakopovic, Marko; Knezevic, Jelena; Castaños-Vélez, Esmeralda; Roz, Luca; Pastorino, Ugo; Brustugun, Odd-Terje; Lund-Iversen, Marius; Thunnissen, Erik; Köhler, Jens; Schuler, Martin; Botling, Johan; Sandelin, Martin; Sanchez-Cespedes, Montserrat; Salvesen, Helga B.; Achter, Viktor; Lang, Ulrich; Bogus, Magdalena; Schneider, Peter M.; Zander, Thomas; Ansén, Sascha; Hallek, Michael; Wolf, Jürgen; Vingron, Martin; Yatabe, Yasushi; Travis, William D.; Nürnberg, Peter; Reinhardt, Christian; Perner, Sven; Heukamp, Lukas; Büttner, Reinhard; Haas, Stefan A.; Brambilla, Elisabeth; Peifer, Martin; Sage, Julien; Thomas, Roman K.
    Comprehensive genomic profiles of small cell lung cancer
    In: Nature Jg. 524 (2015) Nr. 7563, S. 47 - 53
    ISSN: 1476-4687; 0028-0836
  • Tewes, Mitra; Kasimir-Bauer, Sabine; Welt, Anja; Schuler, Martin; Kimmig, Rainer; Aktas, Bahriye
    Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 141 (2015) Nr. 1, S. 87 - 92
    ISSN: 0171-5216; 1432-1335
  • Jaeger, Savina; Spreafico, Anna; van Geel, Robin; Bendell, Johanna C.; Lolkema, Martijn P.; Tabernero, Josep; Lenz, Heinz-Josef; Schellens, Jan H. M.; Avsar, Emin; Wainberg, Zev A.; Yoshino, Takayuki; Eskens, Ferry A. L. M.; Sharma, Sunil; Delord, Jean-Pierre; Schuler, Martin; Chatterjee, Arkendu; Faris, Jason E.; Yaeger, Rona; Demuth, Tim; Yamada, Yasuhide
    Final biomarker analysis of the phase I study of the selective BRAF V600 inhibitor encorafenib (LGX818) combined with cetuximab with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF-mutant colorectal cancer
    In: Cancer Research Jg. 75 (2015) Nr. 15 Suppl., S. CT136
    ISSN: 0008-5472
  • Reis, Henning; Herold, Thomas; Ting, S.; Worm, Karl Heinz; Huber, U.; Christoph, Daniel; Eberhardt, Wilfried; Kostbade, K.; Kasper, Stefan; Stamatis, Georgios; Welter, Stefan; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Theegarten, Dirk; Schmidt, K. W.; Schuler, Martin; Wiesweg, Marcel
    HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas
    In: Lung Cancer Jg. 88 (2015) Nr. 1, S. 34 - 41
    ISSN: 0169-5002
  • Yang, James Chih-Hsin; Ahn, Myung-Ju; Dickgreber, Nicolas J.; Halmos, Balazs; Hirsh, Vera; Hochmair, Maximilian J.; Levy, Benjamin Philip; De Marinis, Filippo; Mok, Tony; O´Byrne, Kenneth; Okamoto, Isamu; Schuler, Martin; Sebastian, Martin; Shah, Riyaz N. H; Tan, Eng-Huat; Yamamoto, Nobuyuki; Marten, Angela; Massey, Dan; Wind, Sven; Carbone, David Paul
    Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC)
    In: Journal of Clinical Oncology Jg. 33 (2015) Nr. 15_suppl, S. 8073
    ISSN: 0732-183X; 1527-7755
  • Passaro, A.; Yang, J. C.; Ahn, M.; Dickgreber, N. J.; Halmos, B.; Hirsh, V.; Hochmair, M. J.; Levy, B. P.; de Marinis, F.; Mok, T.; OByrne, K.; Okamoto, I.; Schuler, Martin; Sebastian, M.; Shah, R.; Tan, E.; Yamamoto, N.; Marten, A.; Wind, S.; Carbone, D. P.
    Influence of dose adjustment on afatinib safety and efficacy in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) non-small cell lung cancer (NSCLC)
    In: Annals of Oncology Jg. 26 (2015) Nr. S 6, S. vi73 - vi89
    ISSN: 0923-7534; 1569-8041
  • Mühlenberg, Thomas; Grunewald, Susanne; Treckmann, Jürgen Walter; Podleska, Lars; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian
    Inhibition of KIT-Glycosylation by 2-Deoxyglucose Abrogates KIT-Signaling and Combination with ABT-263 Synergistically Induces Apoptosis in Gastrointestinal Stromal Tumor
    In: PLoS ONE Jg. 10 (2015) Nr. 3, S. e0120531
    ISSN: 1932-6203
  • Stang, Andreas; Schuler, Martin; Kowall, Bernd; Darwiche, Kaid; Kühl, Hilmar; Jöckel, Karl-Heinz
    Lungenkrebsscreening mit Low-Dose-Computertomographie in Deutschland : Hochrechnung der Kennzahlen des National Lung Screening Trial
    In: Deutsches Ärzteblatt international Jg. 112 (2015) Nr. 38, S. 637 - 644
    ISSN: 1866-0452
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, Stephan; Bergmann, Christoph; Brandau, Sven; Abu-Jawad, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Molecular dissection of the impact of frequent genetic alterations on the response of head and neck cancers to anti-epidermal growth factor receptor-directed therapies
    In: Oral Oncology Jg. 51 (2015) Nr. 5, S. e39
    ISSN: 1368-8375; 1879-0593; 0964-1955
  • Wu, Y. L.; Sequist, L. V.; Schuler, Martin; Yamamoto, N.; Zhou, C.; Hu, C. P.; OByrne, K.; Hirsh, V.; Mok, T.; Zazulina, V.; Yang, J. C. H.
    Overall survival (OS) with afatinib (A) vs chemotherapy (CT) in patients (pts) with NSCLC harboring EGFR mutations (mut) : Subgroup analyses by race in LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6)
    In: Annals of Oncology Jg. 26 (2015) Nr. S 9: ESMO Asia Congress, 18-21 December 2015, Singapore : Submitted Abstracts, S. 136
    ISSN: 0923-7534; 1569-8041
  • Janku, F.; Juric, D.; Cortes, J.; Rugo, H.; Burris, H. A.; Schuler, Martin; Deschler-Baier, B.; Middleton, M. R.; Gil-Martin, M.; Berlin, J.; Winer, E.; Bootle, D.; Blumenstein, L.; Demanse, D.; Coughlin, C.; Quadt, C.; Baselga, J.
    Phase I study of the PI3K alpha inhibitor BYL719 plus fulvestrant in patients with PIK3CA-altered and wild type ER+/HER2-locally advanced or metastatic breast cancer
    In: Cancer Research Jg. 75 (2015) Nr. S 9, S. 9 - 13
    ISSN: 0008-5472; 1538-7445; 0099-7013; 0099-7374
  • Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Friedel, Godehard; Veit, Stefanie; Heinrich, Vanessa; Welter, Stefan; Budach, Wilfried; Spengler, Werner; Kimmich, Martin; Fischer, Berthold; Schmidberger, Heinz; De Ruysscher, Dirk; Belka, Claus; Cordes, Sebastian; Hepp, Rodrigo; Lütke-Brintrup, Diana; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin
    Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)
    In: Journal of Clinical Oncology Jg. 33 (2015) Nr. 35, S. 4194 - 4201
    ISSN: 0732-183X; 1527-7755
  • Bauer, Sebastian; Herold, Thomas; Mühlenberg, Thomas; Reis, Anna-Carina; Falkenhorst, Johanna; Backs, Miriam; Ketzer, Julia; Breitenbücher, Frank; Schuler, Martin; Grunewald, Susanne
    Plasma sequencing to detect a multitude of secondary KIT resistance mutations in metastatic gastrointestinal stromal tumors (GIST)
    In: Journal of Clinical Oncology Jg. 33 (2015) Nr. 15_suppl, S. 10518
    ISSN: 0732-183X; 1527-7755
  • Pöttgen, Christoph; Stuschke, Martin; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, Eleni; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, Matthias; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
    In: BMC Cancer Jg. 15 (2015) Nr. 1, S. 363
    ISSN: 1471-2407
  • Gautschi, Oliver; Bluthgen, Marie-Virginia; Smit, Egbert F.; Wolf, Jürgen; Früh, Martin; Petersenn, Stephan; Schuler, Martin; Zalcman, Gérard; Milia, Julie; Mazieres, Julien
    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer : Results from the European EURAF Cohort
    In: Annals of Oncology Jg. 26 (2015) Nr. S 1: European Lung Cancer Conference (ELCC), Geneva, Switzerland, 15-18 April 2015 : Abstracts, S. i61
    ISSN: 0923-7534; 1569-8041
  • Gautschi, Oliver; Milia, Julie; Cabarrou, Bastien; Bluthgen, Marie-Virginia; Besse, Benjamin; Smit, Egbert F.; Wolf, Jürgen; Peters, Solange; Früh, Martin; Koeberle, Dieter; Oulkhouir, Youssouf; Schuler, Martin; Curioni-Fontecedro, Alessandra; Huret, Benjamin; Kerjouan, Mallorie; Michels, Sebastian; Pall, Georg; Rothschild, Sacha I.; Schmid-Bindert, Gerald; Scheffler, Matthias; Veillon, Rémi; Wannesson, Luciano; Diebold, Joachim; Zalcman, Gérard; Filleron, Thomas; Mazières, Julien
    Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort
    In: Journal of Thoracic Oncology Jg. 10 (2015) Nr. 10, S. 1451 - 1457
    ISSN: 1556-1380; 1556-0864
  • Hyman, David M.; Puzanov, Igor; Subbiah, Vivek; Faris, Jason E.; Chau, Ian; Blay, Jean‑Yves; Wolf, Jürgen; Raje, Noopur S.; Diamond, Eli L.; Hollebecque, Antoine; Gervais, Radj; Elez‑Fernandez, Maria Elena; Italiano, Antoine; Hofheinz, Ralf‑Dieter; Hidalgo, Manuel; Chan, Emily; Schuler, Martin; Lasserre, Susan Frances; Makrutzki, Martina; Sirzen, Florin; Veronese, Maria Luisa; Tabernero, Josep; Baselga, José
    Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations
    In: The New England Journal of Medicine Jg. 373 (2015) Nr. 8, S. 726 - 736
    ISSN: 0028-4793
  • Hoffmann, Gesine; Breitenbücher, Frank; Schuler, Martin; Ehrenhofer-Murray, Ann
    A Novel Sirtuin 2 (SIRT2) Inhibitor with p53-dependent Pro-apoptotic Activity in Non-small Cell Lung Cancer
    In: Journal of Biological Chemistry Jg. 289 (2014) Nr. 8, S. 5208 - 5216
    ISSN: 0021-9258; 1083-351X
  • Wiesweg, M; Aydin, S; Köninger, Angela; Stein, Anja; Schara, Ulrike; van Roye, C; Hense, Jörg; Welt, Anja; Schuler, Martin
    Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy : A Case Report and Review of the Literature
    In: AJP Reports Jg. 4 (2014) Nr. 1, S. 017 - 022
    ISSN: 2157-6998
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D; O'Shannessy, Daniel J; Gauler, Thomas; Wohlschläger, Jeremias; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R
    Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients
    In: Clinical Lung Cancer Jg. 15 (2014) Nr. 5, S. 320 - 330.e3
    ISSN: 1525-7304; 1938-0690
  • Holczyk, M.; Herbrik, M.; Grabellus, Florian; Podleska, Lars; Pöttgen, Christoph; Schwindenhammer, B.; Bekas, V.; Schuler, Martin; Bauer, Sebastian
    Brain metastases in sarcoma patients : Incidence and outcome
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 10591
    ISSN: 0732-183X; 1527-7755
  • Shaw, A.; Mehra, R.; Tan, DSW; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraldes, M.; Sen, P.; Boral, A. J.; Yovine, A.; Kim, D. W.
    Ceritinib (LDK378) for treatment of patients with ALK-rearranged (ALK plus) non small cell lung cancer (NSCLO) and brain metastases (BM) in the ascend-1 trial
    In: Neuro-Oncology Jg. 16 (2014) Nr. Suppl. 5, S. v39
    ISSN: 1522-8517; 1523-5866
  • Shaw, Alice T; Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Juergen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Lau, Yvonne Y; Goldwasser, Meredith; Boral, Anthony L; Engelman, Jeffrey A
    Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
    In: The New England Journal of Medicine Jg. 370 (2014) Nr. 13, S. 1189 - 1197
    ISSN: 0028-4793; 1533-4406
  • Tan, DSW; Shaw, A. T.; Mehra, R.; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J. F.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraides, M.; Boral, A.; Yovine, A. J.; Kim, D. W.
    Ceritinib in Asian versus Caucasian patients (Pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) NSCLC : Subgroup analysis of the ASCEND-1 trial
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 8078
    ISSN: 0732-183X; 1527-7755
  • Kim, D. W.; Mehra, R.; Tan, DSW; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J. F.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraldes, M.; Boral, A.; Yovine, A. J.; Shaw, A. T.
    Ceritinib in advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK plus ) non-small cell lung cancer (NSCLC) : Results of the ASCEND-1 trial
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 8003
    ISSN: 0732-183X; 1527-7755
  • Schuler, Martin; Yang, C. H.; Park, K.; Bennouna, J.; Chen, Y. M.; Chouaid, C.; De Marinis, F.; Feng, J. F.; Grossi, F.; Kim, D. W.; Liu, X. Q.; Lu, S.; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C. C.; Chand, V. K.; Wang, B. S.; Kim, J. H.; Planchard, D.; LUX-Lung 5 Investigators
    Continuation of afatinib beyond progression : Results of a randomized, open-label, phase III trial of afatanib plus paclitaxel (P) versus investigators choice chemotherapy (CT) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) progressed
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 8019
    ISSN: 0732-183X; 1527-7755
  • Gauler, Thomas; Espenhain, L.; Hoiczyk, M.; Nel, I.; Parr, A.; Roder, J.; Schuler, Martin; Eberhardt, Wilfried; Roder, H.; Hoffmann, Andreas-Claudius
    Correlation of proteomics and first-line platinum-based chemotherapy in stage NSCLC in a large single-center cohort
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl.,
    ISSN: 0732-183X; 1527-7755
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried
    Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 1 Suppl., S. S146 - S147
    ISSN: 0360-3016
  • Wu, Y. L.; Sequist, L.; Hu, C. P.; Feng, J. F.; Lu, S.; Huang, Y. C.; Li, W.; Hou, M.; Schuler, Martin; Mok, T.; Yamamoto, N.; OByrne, K.; Hirsh, V.; Gibson, N.; Massey, D.; Kim, M.; Yang, JCH
    Detection of Epidermal Growth Factor Receptor (EGFR) Mutations in Circulating Cell-Free DNA in Two Phase III Studies (LUX-Lung 3 and LUX-Lung 6) of Afatinib vs Platinum-Based Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer
    In: American Journal of Clinical Pathology Jg. 142 (2014) Nr. Suppl. 1, S. A182
    ISSN: 0002-9173
  • Aktas, B.; Kasimir-Bauer, Sabine; Welt, Anja; Schuler, Martin; Kimmig, Rainer; Tewes, Mitra
    Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancer
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. e22032
    ISSN: 0732-183X; 1527-7755
  • Breitenbücher, Frank; Hoffarth, Sandra; Worm, Karl; Cortes-Incio, Diana; Gauler, Thomas; Köhler, Jens; Herold, Thomas; Kurt Werner, Schmid; Freitag, Lutz; Kasper, Stefan; Schuler, Martin
    Development of a Highly Sensitive and Specific Method for Detection of Circulating Tumor Cells Harboring Somatic Mutations in Non-Small-Cell Lung Cancer Patients
    In: PLoS ONE Jg. 9 (2014) Nr. 1, S. e85350
    ISSN: 1932-6203
  • Grunewald, Susanne; Mühlenberg, Thomas; Rubin, B.; Schuler, Martin; Fletcher, J. A.; Bauer, Sebastian
    Effect of secondary KIT mutations on growth of GIST cells in the absence of selective pressure by imatinib in isogenic models of imatinib resistance
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 10555
    ISSN: 0732-183X; 1527-7755
  • Kim, D.; Mehra, R.; Tan, DSW; Felip, E.; Chow, LQM; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; Riely, G. J.; Solomon, B. J.; Wolf, J.; Thomas, M.; Schuler, Martin; Liu, G.; Santoro, A.; Geraldes, M.; Boral, A. L.; Yovine, A.; Shaw, A. T.
    Efficacy and Safety of Ceritinib in Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) : An Update of ASCEND-1: Metastatic Non-Small Cell Lung Cancer
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5 Suppl., S. S33 - S34
    ISSN: 0360-3016
  • Wu, Y.; Geater, S. L.; Mok, T.; OByrne, K. J.; Schuler, Martin; Sequist, L. V.; Yang, J. C.; Massey, D.; OBrien, D.; Zazulina, V.
    Epidermal Growth Factor Receptor (EGFR)-Mediated Adverse Events (AEs) in Patients (pts) With EGFR-Mutation Positive (EGFR M+) Non-Small Cell Lung Cancer (NSCLC) Treated With Afatinib (A) : Metastatic Non-Small Cell Lung Cancer
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5 Suppl., S. 41
    ISSN: 0360-3016
  • Schuler, Martin; Fischer, Jürgen R; Grohé, Christian; Gütz, Sylvia; Thomas, Michael; Kimmich, Martin; Schneider, Claus-Peter; Laack, Eckart; Märten, Angela; for the Afatinib Compassionate Use Consortium; Cortes-Incio, D; Gauler, Thomas
    Experience With Afatinib in Patients With Non-Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib
    In: The Oncologist Jg. 19 (2014) Nr. 10, S. 1100 - 1109
    ISSN: 1083-7159
  • Kohler, J.; Schuler, Martin; Kasper, Stefan; Nensa, Felix; Hense, Jörg; Forsting, Michael; Kuhl, H.
    Formation of multiple pneumatoceles during anti-angiogenic treatment for metastatic colorectal cancer
    In: Oncology Research and Treatment / Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg Jg. 37 (2014) Nr. Suppl. 5, S. 84 - 85
    ISSN: 2296-5262
  • Göbel, C.; Breitenbücher, Frank; Kalkavan, H.; Hähnel, Patricia S.; Kasper, Stefan; Hoffarth, Christian; Merches, Katja; Schild, Hans-Jörg; Lang, Karl S.; Schuler, Martin
    Functional expression cloning identifies COX-2 as a suppressor of antigen-specific cancer immunity
    In: Cell Death and Disease Jg. 5 (2014) Nr. 12, S. 1568
    ISSN: 2041-4889
  • Pogorzelski, M-; Ting, Saskia; Gauler, Thomas; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Markowetz, J.; Lang, S.; Bergmann, Christoph; Brandau, Sven; Abu Jawad, Jehad; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy
    In: Cell Death and Disease Jg. 5 (2014) Nr. 2, S. e1091
    ISSN: 2041-4889
  • Köhler, Jens; Schuler, Martin
    LUX-Lung 3: redundancy, toxicity or a major step forward? : Afatinib as front-line therapy for patients with metastatic EGFR-mutated lung cancer
    In: Future Oncology Jg. 10 (2014) Nr. 4, S. 533 - 540
    ISSN: 1744-8301; 1479-6694
  • Wiesweg, Marcel; Schuler, Martin
    Molekulare Labordiagnostik bei gastrointestinalen Tumorerkrankungen
    In: Der Gastroenterologe Jg. 9 (2014) Nr. 2, S. 127 - 137
    ISSN: 1861-969X
  • Sequist, L.; Wu, Y.; Schuler, Martin; OByrne, K.; Sebastian, M.; Popat, S.; Boyer, M.; Mok, T.; Yamamoto, N.; Hirsh, V.; Geater, S. L.; Zhou, C.; Massey, D.; Zazulina, V.; Jones, H.; Yang, J.
    Overall Survival (OS) With Afatinib Versus Chemotherapy in Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC) Harboring Common (Del19/L858R) Epidermal Growth Factor Receptor Mutations (EGFR Mut) : Results of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6): Metastatic Non-Small Cell Lung Cancer
    In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5 Suppl., S. S5 - S6
    ISSN: 0360-3016
  • Yang, JCH; Sequist, L. V.; Schuler, Martin; Mok, T.; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Geater, S. L.; Zhou, C. C.; Massey, D.; Zazulina, V.; Wu, Y. L.
    Overall survival (OS) in patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring common (Del19/L858R) epidermal growth factor receptor mutations (EGFR mut) : Pooled analysis of two large open-label phase III studies (LUX-Lung 3 [LL3] and
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 8004
    ISSN: 0732-183X; 1527-7755
  • Sequist, L. V.; Cassier, P.; Varga, A.; Tabernero, J.; Schellens, J. H.; Delord, J. P.; LoRusso, P.; Camidge, D. R.; Medina, M. H.; Schuler, Martin; Campone, M.; Tian, G. G.; Wong, S.; Corral, J.; Isaacs, R.; Sen, S. K.; Porta, D. G.; Kulkarni, S. G.; Lefebvre, C.; Wolf, J.
    Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors
    In: Cancer Research Jg. 74 (2014) Nr. 19 Suppl.,
    ISSN: 0008-5472; 1538-7445
  • Van Geel, R.; Elez, E.; Bendell, J. C.; Faris, J. E.; Lolkema, MPJK; Eskens, F.; Spreafico, A.; Kavan, P.; Delord, J. P.; Schuler, Martin; Wainberg, Z. A.; Yamada, Y.; Yoshino, T.; Demuth, T.; Avsar, E.; Chatterjee, A.; Zhu, P. J.; Bernards, R.; Tabernero, J.; Schellens, JHM
    Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor BYL719 in patients with advanced BRAF-mutant colorectal cancer
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 3514
    ISSN: 0732-183X; 1527-7755
  • Tabernero, J.; van Geel, R.; Bendell, J. C.; Spreafico, A.; Schuler, Martin; Yoshino, T.; Delord, J. P.; Yamada, Y.; Lolkema, M. P.; Fans, J. E.; Eskens, FALM; Sharma, S.; Yaeger, R.; Lenz, H. J.; Wainberg, Z.; Avsar, E.; Chatterjee, A.; Jaeger, S.; Demuth, T.; Schellens, JHM
    Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer
    In: European Journal of Cancer Jg. 50 (2014) Nr. Suppl. 6, S. 199
    ISSN: 0959-8049
  • Eberhardt, Wilfried; Gauler, Thomas; Pöttgen, Christoph; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Kimmich, M.; Fischer, B.; Schmidberger, H.; Gkika, E.; Cordes, S.; Hepp, R.; Luetke-Brintrup, D.; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin; ESPATUE AIO ARO Clinical Trials
    Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 7510
    ISSN: 0732-183X; 1527-7755
  • Bauer, Sebastian; Hilger, Ralf A.; Mühlenberg, Thomas; Grabellus, Florian; Nagarajah, James; Hoiczyk, M.; Reichardt, A.; Ahrens, M.; Reichardt, P.; Grunewald, S.; Scheulen, Max Ernst; Pustowka, A.; Bock, E.; Schuler, Martin; Pink, D.
    Phase i study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
    In: The British Journal of Cancer: BJC Jg. 110 (2014) Nr. 5, S. 1155 - 1162
    ISSN: 1532-1827; 0007-0920
  • Ahnert, J. R.; Schuler, Martin; Machiels, JPH; Hess, D.; Paz-Ares, L.; Awada, A.; von Moos, R.; Steeghs, N.; Zambrano, C. C.; De Mesmaeker, P.; Richly, Heike; Herremans, C.; Joerger, M.; Jaime, J. C.; Alsina, M.; Baffert, F.; Demanse, D.; Duval, V.; Morozov, A.; Dirix, L.
    Phase lb study of BEZ235 plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+ breast cancer (BC)
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 621
    ISSN: 0732-183X; 1527-7755
  • Zambrano, C. C.; Schuler, Martin; Machiels, JPH; Hess, D.; Paz-Ares, L.; Awada, A.; von Moos, R.; Steeghs, N.; Ahnert, J. R.; De Mesmaeker, P.; Richly, Heike; Herremans, C.; Joerger, M.; Jaime, J. C.; Alsina, M.; Baffert, F.; Demanse, D.; Duval, V.; Morozov, A.; Dirix, L.
    Phase lb study of buparlisib (BKM120) plus either paclitaxel (PTX) in advanced solid tumors (aST) or PTX plus trastuzumab (TZ) in HER2+ breast cancer (BC)
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 627
    ISSN: 0732-183X; 1527-7755
  • Kuehnle, Marie-Christine; Attig, Sebastian; Britten, Cedrik Michael; Schulze-Bergkamen, Henning; Lordick, Florian; Von Wichert, Götz P. L .; Thuß-Patience, Peter C.; Stein, Alexander; Schuler, Martin; Bassermann, Florian; Şahin, Uǧur; Türeci, Özlem
    Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction
    In: Cancer Immunology, Immunotherapy Jg. 63 (2014) Nr. 12, S. 1273 - 1284
    ISSN: 0340-7004
  • Schmidt, Lars Henning; Görlich, Dennis; Spieker, Tillmann; Rohde, Christian; Schuler, Martin; Mohr, Michael; Humberg, Julia; Sauer, Tim; Thoenissen, Nils; Huge, Andreas; Voss, Reinhard; Marra, Alessandro; Faldum, Andreas; Müller-Tidow, Carsten; Berdel, Wofgang E.; Wiewrodt, Rainer
    Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non-small-cell lung cancer
    In: Journal of Thoracic Oncology Jg. 9 (2014) Nr. 9, S. 1294 - 1304
    ISSN: 1556-1380; 1556-0864
  • Kordelas, L.; Bauer, Sebastian; Schuler, Martin; Beelen, Dietrich; Gauler, Thomas
    Successful resuscitation of a patient with ventricular fibrillation due to hypomagnesemia under cetuximab therapy
    In: TumorDiagnostik & Therapie Jg. 35 (2014) Nr. 1, S. 25 - 27
    ISSN: 1439-1279; 0722-219X
  • Kasper, Stefan; Schuler, Martin
    Targeted therapies in gastroesophageal cancer
    In: European Journal of Cancer Jg. 50 (2014) Nr. 7, S. 1247 - 1258
    ISSN: 1879-0852; 0959-8049
  • Nogova, L.; Sequist, L. V.; Cassier, P. A.; Hidalgo, M.; Delord, J. P.; Schuler, Martin; Lim, W. T.; Camidge, D. R.; Buettner, R.; Heukamp, L. C.; Gardizi, M.; Scheffler, M.; Kambartel, K.; Ringeisen, F. P.; Sen, S.; Isaacs, R.; Joannaert, M.; Lefebvre, C.; Wolf, J.
    Targeting FGFR1-amplified lung squamous cell carcinoma with the selective pan-FGFR inhibitor BGJ398
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15 Suppl., S. 8034
    ISSN: 0732-183X; 1527-7755
  • Mühlenberg, T.; Grunewald, S.; Schuler, Martin; Bauer, Sebastian
    Targeting glucose metabolism by 2-deoxyglucose in gastrointestinal stromal tumors
    In: Cancer Research Jg. 74 (2014) Nr. 19 Suppl.,
    ISSN: 0008-5472; 1538-7445
  • Pastille, Eva; Bardini, Katrin; Fleissner, Diana; Adamczyk, Alexandra; Frede, Annika; Wadwa, Munisch; Smolinski, Dorthe von; Kasper, Stefan; Sparwasser, Tim; Gruber, Achim D.; Schuler, Martin; Sakaguchi, Shimon; Roers, Axel; Müller, Werner; Hansen, Wiebke; Buer, Jan; Westendorf, Astrid
    Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer
    In: Cancer Research Jg. 74 (2014) Nr. 16, S. 4258 - 4269
    ISSN: 0008-5472; 1538-7445
  • Köhler, J.; Schuler, Martin
    Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma : A Review
    In: Oncology Research and Treatment Jg. 36 (2013) Nr. 9, S. 510 - 518
    ISSN: 0378-584X; 1423-0240
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hoehler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Schuler, Martin; Trarbach, Tanja
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) : An interim analysis of the CEBIFOX trial
    In: Journal of Clinical Oncology Jg. 31 (2013) Nr. 15 Suppl., S. e14502
    ISSN: 0732-183X; 1527-7755
  • Chen, Xiaofeng; Zhu, Quan; Zhu, Lingjun; Pei, Dong; Liu, Yiqian; Yin, Yongmei; Schuler, Martin; Shu, Yongqian
    Clinical perspective of afatinib in non-small cell lung cancer
    In: Lung Cancer Jg. 81 (2013) Nr. 2, S. 155 - 161
    ISSN: 0169-5002
  • Juntermanns, Benjamin; Sotiropoulos, Georgios; Radunz, Sonia; Reis, Henning; Heuer, Matthias; Baba, Hideo Andreas; Canbay, Aliekber; Schuler, Martin; Gerken, Guido; Paul, Andreas; Kaiser, Gernot Maximil
    Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
    In: Annals of Surgical Oncology Jg. 20 (2013) Nr. 1, S. 277 - 284
    ISSN: 1068-9265; 1534-4681
  • Heusch, Philipp; Buchbender, Christian; Köhler, Jens; Nensa, Felix; Beiderwellen, Karsten; Kühl, Hilmar; Lanzman, Rotem S.; Wittsack, Hans-Jörg; Gomez, Benedikt; Gauler, Thomas; Schuler, Martin; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald; Heusner, Till Alexander
    Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions : Initial results
    In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren Jg. 185 (2013) Nr. 11, S. 1056 - 1062
    ISSN: 0340-1618; 1438-9010; 1438-9029
  • Simon, Susanne; Grabellus, Florian; Ferrera, Loretta; Galietta, Luis; Schwindenhammer, Benjamin; Mühlenberg, Thomas; Täger, Georg; Eilers, Grant; Treckmann, Jürgen Walter; Breitenbücher, Frank; Schuler, Martin; Taguchi, Takahiro; Fletcher, Jonathan A.; Bauer, Sebastian
    DOG1 Regulates Growth and IGFBP5 in Gastrointestinal Stromal Tumors
    In: Cancer Research Jg. 73 (2013) Nr. 12, S. 3661 - 3670
    ISSN: 0008-5472; 1538-7445
  • Yang, JCH; Sequist, L.; OByrne, K.; Schuler, Martin; Mok, T.; Geater, S.; Massey, D.; OBrien, D.; Zazulina, V.; Wu, Y. L.
    Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib
    In: European Journal of Cancer Jg. 49 (2013) Nr. Suppl. 2, S. 190
    ISSN: 0959-8049
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin
    Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center
    In: European Journal of Cancer Jg. 49 (2013) Nr. 15, S. 3076 - 3082
    ISSN: 0959-8049; 1879-0852
  • Nel, I.; Gauler, Thomas; Eberhardt, Wilfried; Nickel, A. C.; Schuler, Martin; Thomale, Jürgen; Hoffmann, Andreas-Claudius
    Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment
    In: The British Journal of Cancer: BJC Jg. 109 (2013) Nr. 5, S. 1223 - 1229
    ISSN: 1532-1827; 0007-0920
  • Rebmann, Vera; Gauler, Thomas; Schott, B.; Schott, P.; Bauer, Sebastian; Opalka, Bertram; Stamatis, Georgios; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter
    Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patients
    In: Tissue Antigens Jg. 81 (2013) Nr. 5, S. 282 - 283
    ISSN: 0001-2815; 1399-0039
  • Falkenhorst, J.; Mühlenberg, Thomas; Grunewald, S.; Marino-Enriquez, A.; Schuler, Martin; Fletcher, J.; Bauer, Sebastian;
    IAP gene alterations and therapeutic modulation of IAPs by Smac mimetics in GIST
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 245 - 246
    ISSN: 0378-584X; 1423-0240
  • OByrne, K. J.; Sequist, L. V.; Schuler, Martin; Yamamoto, N.; Hirsh, V.; Mok, T.; Lungershausen, J.; Shahidi, M.; Palmer, M.; Yang, JCH
    LUX-Lung 3 : Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations
    In: Lung Cancer Jg. 79 (2013) Nr. Suppl. 1, S. 11
    ISSN: 0169-5002
  • Kasper, Stefan; Breitenbücher, Frank; Reis, Henning; Brandau, Sven; Worm, K.; Köhler, J.; Paul, Andreas; Trarbach, Tanja; Schmid, Kurt Werner; Schuler, Martin
    Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade
    In: Oncogene Jg. 32 (2013) Nr. 23, S. 2873 - 2881
    ISSN: 1476-5594
  • Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin
    Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations
    In: Journal of Clinical Oncology Jg. 31 (2013) Nr. 27, S. 3327 - 3334
    ISSN: 0732-183X; 1527-7755
  • Nell, I.; Gauler, Thomas; Nickel, A. C.; Alotaibi, S.; Thomale, Jürgen; Schuler, Martin; Hoffmann, Andreas-Claudius
    Pre-therapeutic ex-vivo repair kinetics of cisplatin-DNA-adducts in circulating tumor cells (CTC) as platinum resistance test
    In: Lung Cancer Jg. 79 (2013) Nr. Suppl. 1, S. 2
    ISSN: 0169-5002
  • Welt, Anja; Tewes, Mitra; Aktas, Bahriye; Hoffmann, Oliver; Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Richly, Heike; Hense, Jörg; Palmer, Michael R.; Lee, Benjamin H.; Wendling, Johanna; Kossow, Josef; Scheulen, Max Ernst; Lehnerdt, Cathrin; Kohl, Marzena; Derks, Cordula; Skottky, Silke; Haus, Ulrike; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Kasper, Stefan
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Breast Cancer Research and Treatment Jg. 142 (2013) Nr. 1, S. 81 - 88
    ISSN: 1573-7217; 0167-6806
  • Juric, D.; Gonzalez-Angulo, A. M.; Burris, H. A.; Schuler, Martin; Schellens, J.; Berlin, J.; Gupta, A.; Seggewiss-Bernhardt, R.; Adamo, B.; Gil-Martin, M.; Bootle, D.; Boehm, M.; De Buck, S.; Demanse, D.; Quadt, C.; Baselga, J.
    Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific P13K inhibitor in combination with fulvestrant : Results from a phase I study
    In: Cancer Research Jg. 73 (2013) Nr. Suppl. 24,
    ISSN: 0008-5472; 1538-7445
  • Gonzalez-Angulo, A. M.; Juric, D.; Argiles, G.; Schellens, JHM; Burris, H. A.; Berlin, J.; Middleton, M. R.; Schuler, Martin; Van Geel, R.; Helgason, T.; Bootle, D.; Boehm, M.; Goggin, T. K.; Demanse, D.; Quadt, C.; Baselga, J.
    Safety, pharmacokinetics, and preliminary activity of the α-specific PI3K inhibitor BYL719 : Results from the first-in-human study
    In: Journal of Clinical Oncology Jg. 31 (2013) Nr. 15 Suppl., S. 2531
    ISSN: 0732-183X; 1527-7755
  • Schuler, Martin; Zvirbule, Z.; Lordick, F.; Krilova, A.; Helbig, U.; Schulze-Bergkamen, H.; Thuss-Patience, P. C.; von Wichert, G.; Schulmann, K.; Trarbach, Tanja; Bauer, Sebastian; Mueller, C.; Al-Batran, S. E.; Huber, C.; Sahin, U.; Tureci, O.
    Safety, tolerability, and efficacy of the first-in-class antibody IMAB362 targeting claudin 18.2 in patients with metastatic gastroesophageal adenocarcinomas
    In: Journal of Clinical Oncology Jg. 31 (2013) Nr. 15 Suppl., S. 4080
    ISSN: 0732-183X; 1527-7755
  • Grunewald, S.; Mühlenberg, Thomas; Ketzer, J.; Backs, M.; Rubin, B.; Schuler, Martin; Fletcher, J.; Bauer, Sebastian;
    Secondary KIT mutations negatively impact cell growth in a novel isogenic model of imatinib-resistance in GIST
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 178 - 179
    ISSN: 0378-584X; 1423-0240
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D.; O'Shannessy, Daniel J.; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Hoiczyk, M.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 1, S. 19 - 30
    ISSN: 1556-1380; 1556-0864
  • Molzan, M.; Kasper, Stefan; Röglin, L.; Skwarczynska, M.; Sassa, T.; Inoue, T.; Breitenbücher, Frank; Ohkanda, J.; Kato, N.; Schuler, Martin; Ottmann, C.
    Stabilization of Physical RAF/14-3-3 Interaction by Cotylenin A as Treatment Strategy for RAS Mutant Cancers
    In: ACS Chemical Biology Jg. 8 (2013) Nr. 9, S. 1869 - 1875
    ISSN: 1554-8937; 1554-8929
  • Yang, James Chih-Hsin; Hirsh, Vera; Schuler, Martin; Yamamoto, Nobuyuki; O'Byrne, Kenneth J.; Mok, Tony S.K.; Zazulina, Victoria; Shahidi, Mehdi; Lungershausen, Juliane; Massey, Dan; Palmer, Michael; Sequist, Lecia V.
    Symptom control and quality of life in lux-lung 3 : A phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations
    In: Journal of Clinical Oncology Jg. 31 (2013) Nr. 27, S. 3342 - 3350
    ISSN: 0732-183X; 1527-7755
  • Hoiczyk, Mathias; Grabellus, Florian; Podleska, Lars; Ahrens, Marit; Schwindenhammer, Benjamin; Täger, Georg; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian
    Trabectedin in metastatic soft tissue sarcomas : Role of pretreatment and age
    In: International Journal of Oncology Jg. 43 (2013) Nr. 1, S. 23 - 28
    ISSN: 1791-2423; 1791-2423
  • Schmidt, L. H.; Spieker, T.; Schuler, Martin; Marra, A.; Wiebe, K.; Berdel, W.; Mueller-Tidow, C.; Rainer, W.
    Tumor laterality influences the prognostic impact of Bcl-2 expression in curatively resected NSCLC patients
    In: Eur Respir J Jg. 42 (2013) Nr. Suppl. 57,
    ISSN: 0903-1936; 1399-3003
  • Schuler, Martin
    Ärztliche Behandlung von an Krebs Erkrankten : Alles ganz anders?
    In: Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen Jg. 107 (2013) Nr. 2, S. 116 - 119
    ISSN: 1865-9217; 2212-0289
  • Schuler, Martin; Awada, Ahmad; Harter, Philipp; Canon, Jean Luc; Possinger, Kurt; Schmidt, Marcus; De Grève, Jacques; Neven, Patrick; Dirix, Luc; Jonat, Walter; Beckmann, Matthias W.; Schütte, Jochen; Fasching, Peter A.; Gottschalk, Nina; Besse-Hammer, Tatiana; Fleischer, Frank; Wind, Sven; Uttenreuther-Fischer, Martina; Piccart, Martine; Harbeck, Nadia
    A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
    In: Breast Cancer Research and Treatment Jg. 134 (2012) Nr. 3, S. 1149 - 1159
    ISSN: 0167-6806; 1573-7217
  • Yang, J. C.; Schuler, Martin; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Mok, TSK; Massey, D.; Zazulina, V.; Shahidi, M.; Sequist, L. V.
    Activity of afatinib in uncommon epidermal growth factor receptor (EGFR) mutations in Lux-Lung 3, a phase III trial of afatinib or cisplatin/pemetrexed EGFR mutation-positive lung cancer
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 410 - 411
    ISSN: 0923-7534; 1569-8041
  • Kim, J. H.; Grossi, F.; De Marinis, F.; Cobo, M.; Yang, JCH; Ragulin, Y.; Bondarenko, I. N.; Chand, V. K.; Wang, B. S.; Gracien, E.; Schuler, Martin
    Afatinib monotherapy in patients with metastatic squamous cell carcinoma of the lung progressing after erlotinib/gefitinib (E/G) and chemotherapy : Interim subset analysis from a phase III trial
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15,
    ISSN: 0732-183X; 1527-7755
  • Scheulen, Max Ernst; Richly, Heike; Kalkavan, H.; Hoffmann, Andreas-Claudius; Virchow, I.; Hilger, Ralf A.; Koeppen, Susanne; Sure, Ulrich; Schuler, Martin; Hense, Jörg
    An investigator-initiated monocentric phase I dose escalation trial of temsirolimus and irinotecan (TEMIR) in patients with relapsing glioblastoma multiforme (reGBM)
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. 2086
    ISSN: 0732-183X; 1527-7755
  • Kasper, Stefan; Meiler, Johannes; Schuler, Martin
    Antikörper zur adoptiven Immuntherapie solider Tumoren
    In: Der Onkologe Jg. 18 (2012) Nr. 9, S. 757 - 769
    ISSN: 0947-8965; 1433-0415
  • Olschlager, K.; Grabellus, Florian; Schnell, R.; Geffken, M.; Hoiczyk, M.; Ahrens, M.; Podleska, Lars; Tager, G.; Treckmann, Jürgen Walter; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian
    Chemotherapy in resectable sarcomas with complex karyotypes - a single center retrospective analysis
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 150 - 150
    ISSN: 0378-584X; 1423-0240
  • Christoph, Daniel; Hoffmann, Andreas-Claudius; Gauler, Thomas; Asuncion, Bernadette Reyna; Loewendick, Heike; Peglow, Anja; Hassan, Biftu; Tran, Cindy; Wynes, Murry W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 4, S. 766 - 767
    ISSN: 1556-1380; 1556-0864
  • Wolf, J.; Nogova, L.; Heukamp, L. C.; Bos, M.; Schuler, Martin; Sequist, L.; Tian, G. G.; Ringeisen, F.; Buettner, R.; Thomas, R.
    Developments in targeted therapy : FGFR1 inhibition in lung cancer
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. Suppl. 6, S. 23
    ISSN: 1556-0864; 1556-1380
  • Drescher, O.; Eberhardt, Wilfried; Prittwitz, R.; Gkika, E.; Korfee, Sönke; Theegarten, Dirk; Welter, Stefan; Krbek, T.; Stamatis, Georgios; Pöttgen, Christoph; Schuler, Martin; Christoph, Daniel
    Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalities
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 140
    ISSN: 0378-584X; 1423-0240
  • Nogova, L.; Gardizi, M.; Bos, MCA; Bitter, E.; Schildhaus, Hans-Ulrich; Heukamp, L. C.; Topelt, K.; Zander, T.; Scheffler, M.; Mattonet, C.; Gokkurt, E.; Risse, F.; Schuler, Martin; Sequist, L.; Tian, G. G.; Ringeisen, F.; Thomas, R.; Buttner, R.; Wolf, J.
    Early clinical evaluation of FGFR1 inhibition in lung cancer : Preliminary results of a phase I study in FGFR1 amplified lung cancer patients treated with BGJ398, a pan FGFR inhibitor
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 137
    ISSN: 0378-584X; 1423-0240
  • Christoph, Daniel; Asuncion, Bernadette Reyna; Mascaux, Celine; Tran, Cindy; Lu, Xian; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Theegarten, Dirk; Neumann, Volker; Hepp, Rodrigo; Welter, Stefan; Stamatis, Georgios; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, S. 1440 - 1448
    ISSN: 1556-1380; 1556-0864
  • Welter, Stefan; Grabellus, Florian; Bauer, Sebastian; Schuler, Martin; Eberhardt, Wilfried; Tötsch, M.; Stamatis, Georgios
    Growth patterns of lung metastases from sarcoma : prognostic and surgical implications from histology
    In: Interactive Cardiovascular and Thoracic Surgery Jg. 15 (2012) Nr. 4, S. 612 - 617
    ISSN: 1569-9293; 1569-9285
  • Kohler, J.; Worm, K.; Gauler, Thomas; Hoiczyk, M.; Theegarten, Dirk; Eberhardt, Wilfried; Hense, Jörg; Breitenbücher, Frank; Schmid, Kurt Werner; Schuler, Martin
    Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) - a single center experience
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 437 - 438
    ISSN: 0923-7534; 1569-8041
  • Pogorzelski, M.; Ting, Saskia; Gauler, Thomas; Vossebein, I.; Breitenbucher, F.; Lang, Stephan; Hoffmann, T. K.; Bergmann, Christoph; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Impact of HPV status on the response of head and neck cancers to the anti-EGFR antibody cetuximab
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 193 - 193
    ISSN: 0378-584X; 1423-0240
  • Meiler, Johannes; Guyot, M.; Hoffarth, S.; Wesarg, E.; Höhn, Y.; Breitenbücher, Frank; Schuler, Martin
    Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 138 (2012) Nr. 8, S. 1385 - 1394
    ISSN: 0171-5216; 1432-1335
  • Falkenhorst, J.; Mühlenberg, Thomas; Simon, S.; Grabellus, Florian; Breitenbucher, F.; Schuler, Martin; Fletcher, J. A.; Bauer, Sebastian
    Inhibitors of Apoptosis Proteins (IAPs) in gastrointestinal stromal tumors - a therapeutic target?
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 249
    ISSN: 0378-584X; 1423-0240
  • Schuler, Martin; Planchard, D.; Yang, JCH; Kim, J. H.; De Marinis, F.; Chen, Y. M.; Zhou, C. C.; Bennouna, J.; Liu, X. Q.; Feng, J. F.; Bidoli, P.; Strausz, J.; Ou, SHI; Chand, V. K.; Wang, B. S.; Munzert, G. M.; Park, K.
    Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigator's choice chemotherapy following progression on afatinib mono
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. 7557
    ISSN: 0732-183X; 1527-7755
  • Schuler, Martin; Planchard, D.; Yang, JCH; Kim, J. H.; De Marinis, F.; Chen, Y. M.; Zhou, C. C.; Bennouna, J.; Liu, X. Q.; Feng, J. F.; Bidoli, P.; Strausz, J.; Ou, SHI; Chand, V. K.; Wang, B. S.; Munzert, G. M.; Park, K.
    Interim analysis of afatinib monotherapy in patients with metastatic NSCLC progressing after chemotherapy and erlotinib/gefitinib (E/G) in a trial of afatinib plus paclitaxel versus investigators choice chemotherapy following progression on afatinib monot
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15,
    ISSN: 0732-183X; 1527-7755
  • Hoiczyk, Mathias; Iliodromitis, Konstantinos; Bauer, Sebastian; Konorza, Thomas; Philipp, Sebastian; Bankfalvi, Agnes; Gerl, Jan Mikael; Schuler, Martin; Erbel, Raimund
    Intimal sarcoma of the pulmonary artery with unusual findings : a case report
    In: Clinical Research in Cardiology Jg. 101 (2012) Nr. 5, S. 397 - 401
    ISSN: 1861-0692
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Investigation of Folate Receptor alpha and Thymidylate Synthase Proteins Expression in metastatic Non-Small Cell Lung Cancer Patients treated with Pemetrexed-based Chemotherapy
    In: Journal of Thorcic Oncology Jg. 7 (2012) Nr. 9, Suppl. 4, S. S211 - S212
    ISSN: 1556-0864; 1556-1380
  • Sequist, L.; Schuler, Martin; Yamamoto, N.; OByrne, K.; Hirsh, V.; Mok, T.; Massey, D.; Zazulina, V.; Shahidi, M.; Yang, J.
    LUX-Lung 3 : A Randomized, Open-Label, Phase III Study of Afatinib vs Pemetrexed and Cisplatin as First-Line Treatment for Patients with Advanced Adenocarcinoma of the Lung Harboring EGFR-Activating Mutations (Subgroup Analysis)
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 4, S. 203
    ISSN: 1556-0864; 1556-1380
  • Sequist, L. V.; Schuler, Martin; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Mok, TSK; Lungershausen, J.; Shahidi, M.; Palmer, M.; Yang, J. C.
    LUX-Lung 3 : Symptom and health-related quality of life results from a randomized phase III study in 1st-line advanced NSCLC patients harbouring EGFR mutations
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 402
    ISSN: 0923-7534; 1569-8041
  • Yang, JCH; Schuler, Martin; Yamamoto, N.; OByrne, K. J.; Hirsh, V.; Mok, T.; Geater, S. L.; Orlov, S. V.; Tsai, C. M.; Boyer, M. J.; Su, W. C.; Bennouna, J.; Kato, T.; Gorbunova, V.; Lee, K. H.; Shah, RNH; Massey, D.; Lorence, R. M.; Shahidi, M.; Sequist, L. V.
    LUX-Lung 3 : A randomized, open-label, phase III study of afatinib versus pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. LBA7500
    ISSN: 0732-183X; 1527-7755
  • OByrne, K.; Schuler, Martin; Yamamoto, N.; Hirsh, V.; Mok, T.; Massey, D.; Zazulina, V.; Shahidi, M.; Sequist, L.; Yang, J.
    Lux-Lung 3 : A randomized, open-label, phase III study of afatinib vs. pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR activating mutations
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 7, S. 102
    ISSN: 1556-0864; 1556-1380
  • Boyer, M.; Schuler, Martin; Yamamoto, N.; OByrne, K.; Hirsh, V.; Mok, T.; Massey, D.; Zazulina, V.; Shahidi, M.; Sequist, L.; Yang, J. C.
    Lux-Lung 3 : a randomized, open-label, phase III study of afatinib versus pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harbouring EGFR-activating mutations
    In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 3, S. 161
    ISSN: 1556-0864; 1556-1380
  • Yamamoto, N.; Schuler, Martin; OByrne, K.; Hirsh, V.; Mok, T.; Kato, T.; Yoshioka, H.; Okamoto, I.; Yokoyama, A.; Massey, D.; Jones, H.; Zazulina, V.; Shahidi, M.; Sequist, L.; Yang, JCH
    Lux-LungG 3 : Afatinib versus cisplatin and pemetrexed in Japanese patients with adenocarcinoma of the lung harboring an EGFR mutation
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 11, S. 8
    ISSN: 0923-7534; 1569-8041
  • Köhler, Johannes; Schuler, Martin
    Molekular zielgerichtete Tumortherapien : aktueller Stand und künftige Entwicklungen
    In: TumorDiagnostik & Therapie Jg. 33 (2012) Nr. 6, S. 311 - 314
    ISSN: 1439-1279
  • Henze, Joern; Mühlenberg, Thomas; Simon, Susanne; Grabellus, Florian; Rubin, Brian; Täger, Georg; Schuler, Martin; Treckmann, Jürgen Walter; Debiec-Rychter, Maria; Taguchi, Takahiro; Fletcher, Jonathan A.; Bauer, Sebastian
    P53 modulation as a therapeutic strategy in gastrointestinal stromal tumors
    In: PLoS ONE Jg. 7 (2012) Nr. 5,
    ISSN: 1932-6203
  • Markova, Boyka; Hähnel, Patricia S.; Kasper, Stefan; Herbertz, Stephan; Schuler, Martin; Breitenbücher, Frank
    Pharmacologic inhibition of mTOR antagonizes the cytotoxic activity of pemetrexed in non-small cell lung cancer
    In: Journal of Cancer Research and Clinical Oncology Jg. 138 (2012) Nr. 4, S. 545 - 554
    ISSN: 1432-1335
  • Ahnert, J. R.; Burris, H. A.; Schellens, JHM; Schuler, Martin; Goodman, O.; Britten, C.; Richards, D.; Demanse, D.; Silva, A.; Baselga, J.
    Phase I Dose-escalation Study of the Oral Dual MTOR/PI3K Inhibitor BEZ235, Solid Dispersion System (SDS) Sachet Formulation, in Patients with Advanced Solid Tumors
    In: European Journal of Cancer Jg. 48 (2012) Nr. Suppl. 6, S. 112
    ISSN: 0959-8049
  • Bauer, Sebastian; Hilger, Ralf A.; Grabellus, Florian; Nagarajah, James; Hoiczyk, M.; Reichardt, A.; Ahrens, M.; Pink, D.; Mühlenberg, Thomas; Scheulen, Max Ernst; Schuler, Martin; Reichardt, P.
    Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST)
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. 10032
    ISSN: 0732-183X; 1527-7755
  • Dirix, L.; Schuler, Martin; Machiels, J.; Hess, D.; Awada, A.; Steeghs, N.; Paz-Ares, L.; von Moos, R.; Rabault, B.; Rodon, J.
    Phase IB dose-escalation study of BEZ235 or BKM 120 in combination with paclitaxel (PTX) in patients with advanced solid tumors
    In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 157 - 158
    ISSN: 0923-7534; 1569-8041
  • Schmidt, Markus; Rüttinger, Dominik; Sebastian, M.; Hanusch, Claus A.; Marschner, Norbert; Bäuerle, Patrick A.; Wolf, Andreas; Göppel, Gertrud; Oruzio, Daniel; Schlimok, Günter; Steger, Günther G.; Wolf, Christopher; Eiermann, Wolfgang; Lang, Alois; Schuler, Martin
    Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with epcampositive relapsed or refractory advanced-stage breast cancer
    In: Annals of Oncology Jg. 23 (2012) Nr. 9, S. 2306 - 2313
    ISSN: 0923-7534; 1569-8041
  • Hoiczyk, M.; Kuschel, P.; Grabellus, Florian; Geffken, M.; Ahrens, M.; Schuler, Martin; Bauer, Sebastian
    Rechallenge with ifosfamide-containing regimen as salvage option for patients with metastatic soft tissue sarcomas progressing after multiple pretreatments
    In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15,
    ISSN: 0732-183X; 1527-7755
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wohlschläger, Jeremias; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Significance of Folate Receptor alpha (FRA) and Thymidylate Synthase (TS) expression in metastatic non-small cell lung cancer patients treated with pemetrexed-based chemotherapy
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 34
    ISSN: 0378-584X; 1423-0240
  • Kasper, Stefan; Breitenbücher, Frank; Heidel, F.; Hoffarth, S.; Markova, B.; Schuler, Martin; Fischer, T.
    Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies
    In: Blood Cancer Journal Jg. 2 (2012) Nr. 3, S. e60
    ISSN: 2044-5385
  • Kasper, Stefan; Reis, Henning; Breitenbücher, Frank; Markowetz, J.; Pogorzelski, M.; Trarbach, Tanja; Worm, K.; Schmid, Kurt Werner; Schuler, Martin
    Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 253
    ISSN: 0378-584X; 1423-0240
  • Welt, Anja; Kossow, J.; Tewes, Mitra; Seeber, S.; Schuler, Martin
    Trends in survival of patients with metastatic breast cancer
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 187
    ISSN: 0378-584X; 1423-0240
  • Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin
    VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center
    In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204
    ISSN: 0378-584X; 1423-0240
  • Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
    In: The British Journal of Cancer: BJC Jg. 107 (2012) Nr. 5, S. 823 - 830
    ISSN: 1532-1827; 0007-0920
  • Ahrens, M.; Hoiczyk, M.; Grabellus, Florian; Täger, Georg; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian
    Angiosarcomas of the adulthood - a large single center analysis
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 254 - 254
    ISSN: 0378-584X; 1423-0240
  • Aktas, B.; Kasimir-Bauer, Sabine; Kasper, Stefan; Derks, C.; Kimmig, Rainer; Schuler, Martin; Tewes, Mitra
    Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative Therapy
    In: Cancer Research Jg. 71 (2011) Nr. Suppl. 24,
    ISSN: 0008-5472; 1538-7445
  • Gauler, Thomas; Theegarten, Dirk; Parr, A.; Schuhr, I.; Schmid, Kurt Werner; Eberhardt, Wilfried; Schuler, Martin; Hoffmann, Andreas-Claudius
    Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer
    In: J Thorac Oncol Jg. 6 (2011) Nr. Suppl. 6, S. 1114
    ISSN: 1556-0864; 1556-1380
  • Simon, S.; Grabellus, Florian; Täger, Georg; Treckmann, Jürgen Walter; Schuler, Martin; Fletcher, J.; Bauer, Sebastian
    Development of xenograft-based in vivo models of gastrointestinal stromal tumors
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 253 - 253
    ISSN: 0378-584X; 1423-0240
  • Livingstone, Elisabeth; Trarbach, Tanja; Zimmer, Lisa; Schuler, Martin; Schadendorf, Dirk
    EGFR-Inhibitoren und Multityrosinkinaseinhibitoren : Interdisziplinäre Behandlung der kutanen Nebenwirkungen
    In: Deutsche Medizinische Wochenschrift Jg. 136 (2011) Nr. 1-2, S. 39 - 44
    ISSN: 1439-4413; 1437-5982; 0012-0472
  • Schmidt, Marcus; Petry, Ilka Brigitte; Böhm, Daniel; Lebrecht, Antje; Törne, Christian von; Gebhard, Susanne; Gerhold-Ay, Aslihan; Cotarelo, Cristina; Battista, Marco; Schormann, Wiebke; Freis, Evgenia; Selinski, Silvia; Ickstadt, Katja; Rahnenführer, Jörg; Sebastian, Martin; Schuler, Martin; Koelbl, Heinz; Gehrmann, Mathias; Hengstler, Jan G.
    Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer
    In: Breast Cancer Research and Treatment Jg. 125 (2011) Nr. 3, S. 637 - 646
    ISSN: 1573-7217; 0167-6806
  • Christoph, DanielC; Kasper, Stefan; Gauler, ThomasC; Breitenbücher, Frank; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Hirsch, FredR; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of Betav-Tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1078
    ISSN: 1556-0864; 1556-1380
  • Christoph, Daniel; Gauler, Thomas; Engelhard, M.; Theegarten, Dirk; Pöttgen, Christoph; Hepp, R.; Schuler, Martin; Hirsch, F.; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)
    In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 4, S. 14
    ISSN: 0959-8049
  • Becker, Silvan; Markova, Boyka; Wiewrodt, Rainer; Hoffarth, Sandra; Hähnel, Patricia S.; Pleiner, Sina; Schmidt, Lars Hennig; Breitenbücher, Frank; Schuler, Martin
    Functional and Clinical Characterization of the Putative Tumor Suppressor WWOX in Non-small Cell Lung Cancer
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 12, S. 1976 - 1983
    ISSN: 1556-1380; 1556-0864
  • Breitenbücher, Frank; Hoffarth, S.; Gauler, Thomas; Stergar, S. L.; Kasper, Stefan; Kohler, J.; Worm, K.; Marten, A.; Schmid, Kurt Werner; Schuler, Martin
    Highly sensitive detection of somatic epidermal growth factor receptor (EGFR) gene mutations in circulating tumor cells (CTC) from patients with non-small cell lung cancer treated with cisplatin/pemetrexed or afatinib
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S956 - S957
    ISSN: 1556-0864; 1556-1380
  • Christoph, DanielC; Wohlschläger, Jeremias; Neumann, Volker; Gauler, ThomasC; Pöttgen, Christoph; Peglow, Anja; Tannapfel, Andrea; Schuler, Martin; Hirsch, FredR; Eberhardt, Wilfried; Theegarten, Dirk
    Impact of dihydrofolate reductase expression for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1052 - S1053
    ISSN: 1556-0864; 1556-1380
  • Philipps, E. S.; Mühlenberg, Thomas; Simon, S.; Ecken, S.; Grabellus, Florian; Täger, Georg; Schuler, Martin; Bauer, Sebastian
    Inhibition of the Ras/Raf/MAPK-pathway in GIST : Therapeutic potential?
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 235 - 235
    ISSN: 0378-584X; 1423-0240
  • Lambertz, N.; Köhler, Johannes; Schulte, D.M.; Kühl, Hilmar; Wohlschläger, Jeremias; Hense, Jörg; Schuler, Martin; Müller, Oliver
    Multivisceral systemic metastases from an intracranial anaplastic meningioma : A case report and review of literature
    In: Clinical Neurology and Neurosurgery Jg. 113 (2011) Nr. 7, S. 592 - 595
    ISSN: 0303-8467; 1872-6968
  • Köhler, Johannes; Schuler, Martin
    Personalisierte medikamentöse Therapie des fortgeschrittenen nichtkleinzelligen Lungenkarzinoms : Der Pfeil des Wilhelm Tell?
    In: Der Onkologe Jg. 17 (2011) Nr. 8, S. 702 - 708
    ISSN: 0947-8965; 1433-0415
  • Kasper, Stefan; Breitenbücher, Frank; Even, A.; Pogorzelski, M.; Hoffarth, S.; Stergar, S. L.; Trarbach, Tanja; Schuler, Martin
    Pharmacological Inhibition of NF-k and PLK-1 to the Opening of the RAS-mediated Resistance to anti-EGFR Antibody therapies in Colorectal cancer *
    In: Der Internist Jg. 52 (2011) Nr. 6, S. 726 - 726
    ISSN: 0020-9554
  • Christoph, Daniel; Schuler, Martin
    Polo-like kinase 1 inhibitors in mono- and combination therapies : A new strategy for treating malignancies
    In: Expert Review of Anticancer Therapy Jg. 11 (2011) Nr. 7, S. 1117 - 1132
    ISSN: 1473-7140; 1744-8328
  • Christoph, DanielC; Mascaux, Celine; Wynes, MurryW; Asuncion, Bernadette; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Neumann, Volker; Pöttgen, Christoph; Tran, Cindy; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, FredR
    Predictive value of thymidylate synthase and Folypoly-Glutamate Synthease for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1092 - S1093
    ISSN: 1556-0864; 1556-1380
  • Christoph, Daniel; Mascaux, C.; Wynes, M. W.; Reyna Asuncion, B.; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Clinical Oncology Jg. 29 (2011) Nr. 15_suppl, S. 7024
    ISSN: 0732-183X; 1527-7755
  • Scheulen, Max Ernst; Nokay, B.; Richly, Heike; Hoffmann, Andreas-Claudius; Kalkmann, J.; Stattaus, Jörg; Bornfeld, Norbert; Schuler, Martin; Hense, Jörg
    Register trial of sorafenib (S) for patients (pts) with metastatic uveal melanoma (metUvMel)
    In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 4, S. S30
    ISSN: 0959-8049
  • Schuler, Martin; Breitenbücher, Frank; Trarbach, Tanja; Brandau, Sven; Schmid, Kurt Werner; Kasper, Stefan
    Simultaneous protection against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR-signaling blockade by oncogenic RAS
    In: Journal of Clinical Oncology Jg. 29 (2011) Nr. Suppl. 4, S. 440
    ISSN: 0732-183X; 1527-7755
  • Schütt, Philipp; Stattaus, Jörg; Schuler, Martin
    Solitärer Lungenrundherd - Weitere Abklärung erforderlich?
    In: TumorDiagnostik & Therapie Jg. 32 (2011) Nr. 1, S. 33 - 37
    ISSN: 1439-1279
  • Mühlenberg, Thomas; Simon, S.; Fletcher, J. A.; Grabellus, Florian; Täger, Georg; Treckmann, Jürgen Walter; Schuler, Martin; Bauer, Sebastian
    The BH3-mimetic ABT-263 enhances the apoptotic response of GIST cells to KIT-inhibitory treatments
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 254
    ISSN: 0378-584X; 1423-0240
  • Hoiczyk, M.; Grabellus, Florian; Täger, Georg; Schuler, Martin; Bauer, Sebastian
    Trabectedin in heavily pretreated and elderly metastatic soft tissue sarcomas - a single center experience
    In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 237 - 237
    ISSN: 0378-584X; 1423-0240
  • Koeppen, Susanne; Hense, Jörg; Nolte, K. W.; Weis, J.; Schuler, Martin
    Treatable Bortezomib-related peripheral neuropathy in multiple myeloma
    In: Journal of Peripheral Nervous Systems Jg. 16 (2011) Nr. Suppl. 3, S. 68
    ISSN: 1085-9489; 1529-8027
  • Christoph, Daniel; Wittkowski, Lukas; Stattaus, Jörg; Pöttgen, Christoph; Keyvani, Kathy; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried
    Very Late and Isolated Leptomeningeal Relapse of a Pulmonary Adenocarcinoma Presenting as Dementia
    In: Onkologie Jg. 34 (2011) Nr. 6, S. 316 - 320
    ISSN: 1423-0240
  • Schütt, Philipp; Müller, Stefan; Matuszczyk, Anna; Schmid, Kurt Werner; Bockisch, Andreas; Schuler, Martin; Mann, Klaus
    Zielgerichtete Therapie für Patienten mit Schilddrüsenkarzinom
    In: TumorDiagnostik & Therapie Jg. 32 (2011) Nr. 5, S. 269 - 276
    ISSN: 1439-1279
  • Schmidt, Martina; Scheulen, Max Ernst; Dittrich, C.; Obrist, P.; Marschner, N.; Dirix, L.; Schmidt, M.; Rüttinger, D.; Schuler, Martin; Reinhardt, C.; Awada, A.
    An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer
    In: Annals of Oncology Jg. 21 (2010) Nr. 2, S. 275 - 282
    ISSN: 0923-7534; 1569-8041
  • Schuler, Martin; Uttenreuther-Fischer, M. M.; Piccart-Gebhart, M. J.; Harbeck, N.; on behalf of the study group and trial team
    BIBW 2992, a novel irreversible EGFR/HER1 and HER2 tyrosine kinase inhibitor, for the treatment of patients with HER2-negative metastatic breast cancer after failure of no more than two prior chemotherapies
    In: Journal of Clinical Oncology Jg. 28 (2010) Nr. Suppl. 15, S. 1065
    ISSN: 0732-183X; 1527-7755
  • Petry, I. B.; Fieber, E.; Schmidt, Marcus; Gehrmann, M.; Gebhard, S.; Hermes, M.; Schormann, W.; Selinski, S.; Freis, E.; Schwender, H.; Brulport, M.; Ickstadt, K.; Rahnenführer, J.; Maccoux, L.; West, J.; Kölbl, H.; Schuler, Martin; Hengstler, J. G.
    ERBB2 Induces an Antiapoptotic Expression Pattern of Bcl-2 Family Members in Node-Negative Breast Cancer
    In: Clinical Cancer Research Jg. 16 (2010) Nr. 2, S. 451 - 460
    ISSN: 1078-0432; 1557-3265
  • Mühlenberg, Thomas; Fletcher, J. A.; Grabellus, Florian; Schuler, Martin; Bauer, Sebastian
    Effective therapeutic sensitization of gastrointestinal stromal tumors by a BH3 mimetic
    In: European Journal of Cancer / EJC Supplements Jg. 8 (2010) Nr. 7, S. 69 - 70
    ISSN: 1359-6349; 1878-1217
  • Köhler, Jens; Breitenbücher, Frank; Schuler, Martin
    Individualisierte Therapie für Patienten mit fortgeschrittenen Lungenkarzinomen
    In: TumorDiagnostik & Therapie Jg. 31 (2010) Nr. 2, S. 79 - 87
    ISSN: 1439-1279; 0722-219X
  • Nguyen, B.; Grabellus, Florian; Hoiczyk, M.; Täger, Georg; Schuler, Martin; Bauer, Sebastian
    Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib (IM)
    In: Journal of Clinical Oncology Jg. 28 (2010) Nr. Suppl. 15, S. 10047
    ISSN: 0732-183X; 1527-7755
  • Hoffmann, Andreas-Claudius; Wild, Peter; Leicht, Christina; Bertz, Simone; Danenberg, Kathleen D.; Danenberg, Peter V.; Stöhr, Robert; Stöckle, Michael; Lehmann, Jan; Schuler, Martin; Hartmann, Arndt
    MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy
    In: Neoplasia: An International Journal for Oncology Research Jg. 12 (2010) Nr. 8, S. 628 - 636
    ISSN: 1522-8002; 1476-5586
  • Waldner, Maximilian J.; Wirtz, Stefan; Becker, Christoph; Seidel, Daniel; Tubbe, Ingrid; Cappel, Kyra; Hähnel, Patricia S.; Galle, Peter R.; Schuler, Martin; Neurath, Markus F.
    Perforin deficiency attenuates inflammation and tumor growth in colitis-associated cancer
    In: Inflammatory Bowel Diseases Jg. 16 (2010) Nr. 4, S. 559 - 567
    ISSN: 1078-0998; 1536-4844
  • Schütt, Philipp; Schütt, Birgit; Switala, Magdalena; Bauer, Sebastian; Stamatis, Georgios; Opalka, Bertram; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter; Rebmann, Vera
    Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients
    In: Human Immunology Jg. 71 (2010) Nr. 5, S. 489 - 495
    ISSN: 0198-8859; 1879-1166
  • Advani, Anjali; Coiffier, Bertrand; Czuczman, Myron S.; Dreyling, Martin; Foran, James; Gine, Eva; Gisselbrecht, Christian; Ketterer, Nicolas; Nasta, Sunita; Rohatiner, Ama; Schmidt-Wolf, Ingo G. H.; Schuler, Martin; Sierra, Jorge; Smith, Mitchell R.; Verhoef, Gregor; Winter, Jane N.; Boni, Joseph; Vandendries, Erik; Shapiro, Mark; Fayad, Luis
    Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma : results of a phase I study
    In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. 12, S. 2085 - 2093
    ISSN: 0732-183X; 1527-7755
  • Köhler, J.; Schuler, Martin
    Targeted Therapies in der Behandlung solider und hämatologischer Neoplasien
    In: TumorDiagnostik & Therapie Jg. 31 (2010) Nr. 3, S. 133 - 142
    ISSN: 1439-1279; 0722-219X
  • Sebastian, Martin; Reck, Martin; Waller, Cornelius F.; Kortsik, Cornelius; Frickhofen, Norbert; Schuler, Martin; Fritsch, Holger; Gaschler-Markefski, Birgit; Hanft, Gertraud; Munzert, Gerd; Pawel, Joachim von
    The efficacy and safety of BI 2536, a novel Plk-1 inhibitor, in patients with stage IIIB/IV non-small cell lung cancer who had relapsed after, or failed, chemotherapy : Results from an open-label, randomized phase ii clinical trial
    In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. 7, S. 1060 - 1067
    ISSN: 1556-1380; 1556-0864
  • Bauer, Sebastian; Mühlenberg, Thomas; Leahy, Michael; Hoiczyk, Mathias; Gauler, Thomas; Schuler, Martin; Looijenga, Leendert
    Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
    In: European Urology Jg. 57 (2010) Nr. 4, S. 679 - 687
    ISSN: 0302-2838; 1421-993X
  • Hoffmann, Andreas-Claudius; Gauler, Thomas; Parr, A.; Eberhardt, Wilfried; Schuler, Martin
    Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancer
    In: Journal of Clinical Oncology (JCO) Jg. 28 S (2010) Nr. 15, S. Abstract7512
    ISSN: 0732-183X; 1527-7755
  • Mühlenberg, Thomas; Zhang, Yixiang; Wagner, Andrew J.; Grabellus, Florian; Bradner, James; Täger, Georg; Lang, Hauke; Taguchi, Takahiro; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian
    Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors
    In: Cancer Research Jg. 69 (2009) Nr. 17, S. 6941 - 6950
    ISSN: 0008-5472; 1538-7445
  • Thaler, Sonja; Hähnel, Patricia S.; Schad, Arno; Dammann, Reinhard; Schuler, Martin
    RASSF1A mediates p21Cip1/Waf1- dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt
    In: Cancer Research Jg. 69 (2009) S. 1748 - 1757
  • Hähnel, Patricia S.; Thaler, Sonja; Antunes, Edite; Huber, Christoph; Theobald, Matthias; Schuler, Martin
    Targeting AKT signaling sensitizes cancer to cellular immunotherapy
    In: Cancer Research Jg. 68 (2008) S. 3899 - 3906
  • Stolz, Claudia; Heß, Georg; Hähnel, Patricia S.; Grabellus, Florian; Hoffarth, Sandra; Schmid, Kurt Werner; Schuler, Martin
    Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to Rituximab-induced apoptosis
    In: Blood Jg. 112 (2008) S. 3312 - 3321
  • Stolz, Claudia; Hess, Georg; Hähnel, Patricia S.; Grabellus, Florian; Hoffarth, Sandra; Schmid, Kurt Werner; Schuler, Martin
    Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis
    In: Blood Jg. 112 (2008) Nr. 8, S. 3312 - 3321
    ISSN: 0006-4971; 1528-0020
  • Bargou, R.; Leo, E.; Zugmeier, G.; Klinger, M.; .Goebeler, M.; Knop, S.; Noppeney, Richard; Viardot, A.; Hess, G.; Schuler, Martin; Einsele, H.; Brandl, C.; Wolf, A.; Kirchinger, P.; Klappers, P.; Schmidt, Markus; Riethmüller, G.; Reinhardt, C.; Baeuerle, P.A.; Kufer, P.
    Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.
    In: Science Jg. 5891 (2008) Nr. 321, S. 974 - 977
  • Hoffarth, Sandra; Zitzer, Alexander; Wiewrodt, Rainer; Hähnel, Patricia S.; Beyer, Vera; Kreft, Andreas; Biesterfeld, Stefan; Schuler, Martin
    pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer
    In: Cell Death and Differentiation Jg. 15 (2008) S. 161 - 170
  • Vorworte / Nachworte

  • Reinmuth, Niels; Schuler, Martin
    Shall we use steroids when treating patients with lung cancer with checkpoint inhibitors?
    In: European Journal of Cancer Jg. 145 (2021) S. 255 - 257
    ISSN: 1879-0852; 0959-8049
  • Schuler, Martin
    Inhibiting fibroblast growth factor receptors in cancer – the next generation
    In: Annals of Oncology Jg. 31 (2020) Nr. 10, S. 1285 - 1286
    ISSN: 1569-8041; 0923-7534
  • Höffken, K.; Heiss, M.M.; Schuler, Martin
    Tumorimmunologie : Beginn einer neuen Ära?
    In: Der Onkologe Jg. 18 (2012) S. 754 - 756
    ISSN: 0947-8965
  • Abstracts

  • Pant, Shubham; Tabernero, Josep; Massard, Christophe; Iyer, Gopa; Witt, Olaf; Doi, Toshihiko; Qin, Shukui; Lu-Emerson, Christine; Hargrave, Darren R.; García-Corbacho, Javier; Little, Shonda Marie; Xia, Qi; Santiago-Walker, Ademi E.; Moy, Christopher; Hammond, Constance; Sweiti, Hussein; Schuler, Martin;
    A phase II open-label study in adult and adolescent patients (pts) with advanced solid tumors harboring fibroblast growth factor receptor (FGFR) gene alterations
    2021 Gastrointestinal Cancers Symposium ; January 15-17, 2021, Virtuell,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 3, Supplement, S. TPS480
    ISSN: 1527-7755; 0732-183X
  • Subbiah, Vivek; Hu, Mimi I-Nan; Gainor, Justin F.; Mansfield, Aaron Scott; Alonso, Guzman; Taylor, Matthew H.; Zhu, Viola Weijia; Garrido, Pilar; Amatu, Alessio; Doebele, Robert C; Cassier, Philippe; Keam, Bhumsuk; Schuler, Martin; Zhang, Hui; Clifford, Corinne; Palmer, Michael; Green, Jennifer; Turner, Christopher D.; Curigliano, Giuseppe;
    Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion–positive solid tumors
    2021 Gastrointestinal Cancers Symposium ; January 15-17, 2021, Virtuell,
    In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 3, Supplement, S. 467 - 467
    ISSN: 1527-7755; 0732-183X
  • Reinisch, Mattea; Nusch, Arndt; Decker, Thomas; Hartkopf, Andreas; Heinrich, Bernhard J.; Kurbacher, Christian M.; Fuchs, Roswitha; Tesch, Hans; Krabisch, Petra; Brucker, Sara Y.; Fehm, Tanja; Janni, Wolfgang; Kuemmel, Sherko; Lüftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Voges, Claudia; Schubert, Jörg; Fasching, Peter A.;
    Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribociclib (lee011) in combination with letrozole : Final results
    San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,
    In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PS10 - 31
    ISSN: 0008-5472; 1538-7445
  • Lopez, Juanita S.; Camidge, Ross; Iafolla, Marco; Rottey, Sylvie; Schuler, Martin; Hellmann, Matthew; Balmanoukian, Ani; Dirix, Luc; Gordon, Michael; Sullivan, Ryan; Henick, Brian S.; Drake, Charles; Wong, Kit; LoRusso, Patricia; Ott, Patrick; Fong, Lawrence; Schiza, Aglaia; Yachnin, Jeffery; Ottensmeier, Christian; Braiteh, Fadi; Bendell, Johanna; Leidner, Rom; Fisher, George; Jerusalem, Guy; Molenaar-Kuijsten, Laura; Schmidt, Marcus; Laurie, Scott A.; Aljumaily, Raid; Rittmeyer, Achim; Gort, Eelke; Melero, Ignacio; Mueller, Lars; Sabado, Rachel; Twomey, Patrick; Huang, Jack; Yadav, Manesh; Zhang, Jingbin; Mueller, Felicitas; Derhovanessian, Evelyna; Sahin, Ugur; Türeci, Özlem; Powles, Thomas;
    Abstract CT301: A phase Ib study to evaluate RO7198457, an individualized Neoantigen Specific immunoTherapy (iNeST), in combination with atezolizumab in patients with locally advanced or metastatic solid tumors
    Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,
    In: Cancer Research Jg. 80 (2020) Nr. 16: Supplement, S. CT301
    ISSN: 1538-7445; 0008-5472
  • Yang, J. C-H.; Schuler, Martin; Popat, S.; Miura, S.; Heeke, S.; Passaro, A.; de Marinis, F.; Park, K.; Kim, E. S.;
    Afatinib in Asian and non-Asian patients (pts) with EGFR mutation positive (EGFRm+) NSCLC harboring major uncommon mutations
    ESMO Asia Virtual Congress 2020 ; 20-22 November 2020,
    In: Annals of Oncology Jg. 31 (2020) Nr. Supplement 6, S. S1396
    ISSN: 0923-7534; 1569-8041
  • Yang, J.C-H.; Schuler, Martin; Popat, Sanjay; Miura, S.; Heeke, S.; Passaro, A.; de Marinis, Filippo; Park, K.; Kim, E.S.
    Afatinib in Asian and non-Asian patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC harboring uncommon mutations
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S860 - S861
    ISSN: 0923-7534
  • Subbiah, Vivek; Hu, Mimi I-Nan; Gainor, Justin F.; Mansfield, Aaron Scott; Alonso, Guzman; Taylor, Matthew H.; Zhu, Viola Weijia; Garrido Lopez, Pilar; Amatu, Alessio; Doebele, Robert C; Cassier, Philippe Alexandre; Keam, Bhumsuk; Schuler, Martin; Zhang, Hui; Clifford, Corinne; Palmer, Michael; Green, Jennifer; Turner, Christopher D.; Curigliano, Giuseppe
    Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion+ solid tumors.
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 109
    ISSN: 0732-183X; 1527-7755
  • Martens, U.; Reiser, M.; Schirrmacher-Memmel, S.; Sellmann, L.; Decker, T.; Schneeweiss, A.; Schuler, Martin; Bengsch, F.; Vannier, C.; Potthoff, K.; Marschner, N.; Kasenda, B.;
    First results from INFINITY - A registry on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 251 - 252
    ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X
  • Peuker, C. A.; Yaghobramzi, S.; Grunert, C.; Keilholz, L.; Henning, S.; Schaper, S.; Brucker, S.; Decker, T.; Fasching, P.; Fehm, T.; Janni, W.; Kümmel, Sherko; Schneeweiss, A.; Schuler, Martin; Lüftner, D.; Busse, A.;
    Influence of CDK4/6 inhibitors on the peripheral immune response in hormone receptor-positive breast cancer
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 159
    ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X
  • Kasper, Stefan; Hofheinz, R.D.; Stintzing, S.; Götze, T.O.; Sinn, M.; Dechow, T.; Ettrich, T.J.; Keitel, V.; Graeven, U.; Fischer von Weikersthal, L.; Kolov, A.; Edelmann, T.; Stein, A.; Trarbach, T.; Junge, S.; Pauligk, C.; Virchow, I.; Siveke, Jens; Al-Batran, S-E.; Schuler, Martin
    Interim safety analysis of the phase IIb study of ramucirumab in combination with TAS102 vs. TAS102 monotherapy in metastatic colorectal cancer : The RAMTAS trial of the German AIO
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S427 - S428
    ISSN: 0923-7534
  • Guberina, Marko; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Herrmann, Ken; Theegarten, Dirk; Aigner, Clemens; Plones, Till; Gauler, Thomas; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Darwiche, Kaid; Stuschke, Martin
    Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention
    In: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S143
    ISSN: 0179-7158; 1439-099X
  • Pöttgen, Christoph; Plajer, D.; Gauler, Thomas; Guberina, Marko; Santiago, Alina; Guberina, Nika; Eberhardt, Wilfried; Schuler, Martin; Darwiche, Kaid; Plönes, Till; Aigner, Clemens; Stuschke, Martin
    Optimierung prognostischer Modelle für das Überleben von Patienten mit lokal fortgeschrittenen kleinzelligen Lungenkarzinomen nach definitiver Radiochemotherapie mittels künstlicher Intelligenz
    In: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S57 - S58
    ISSN: 0179-7158; 1439-099X
  • Röhrig, T.; Oechsel, K.; Schuler, U.; Rosenbruch, J.; Neukirchen, M.; Hense, Jörg; Weber, M.; Nauck, F.; Junghanß, C.; Kramer, T.; Oorschot, B. van; Ostgathe, C.; Thuss-Patience, P.; Schweda, Adam; Ullrich, A.; Teufel, Martin; Schuler, Martin; Tewes, Mitra;
    Palliative knowledge and self-efficacy expectation of residents before and after palliative care unit rotation - A national study project
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 210
    ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X
  • Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael;
    Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137
    ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X
  • Janku, Filip; Elez, Elena; Iyer, Gopa; Yamamoto, Noboru; Tan, Daniel Shao-Weng; Stathis, Anastasios; Stammberger, Uz M.; Evans, Helen; Seroutou, Abdelkader; Mais, Anna; Schuler, Martin
    Phase I dose-finding study of oral ERK1/2 inhibitor LTT462 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations
    In: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 3640
    ISSN: 0732-183X; 1527-7755
  • Schuler, Martin; Tabernero, J.; Massard, C.; Iyer, G. Vasudeva; Witt, Olaf; Doi, T.; Qin, S.; Lu-Emerson, C.; Hargrave, D.; Garcia-Corbacho, J.; Little, S.; Xia, Q.; Santiago-Walker, A.; Moy, C.H.; Hammond, C.; Lau, Y.Y.; Sweiti, H.; Pant, S.
    Phase II, open-label study of erdafitinib in adult and adolescent patients (pts) with advanced solid tumours harboring fibroblast growth factor receptor (FGFR) gene alterations
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. 502 - S503
    ISSN: 0923-7534
  • Hartkopf, Andreas; Nusch, Arnd; Decker, Thomas; Reinisch, Mattea; Heinrich, Bernhard J; Kurbacher, Christian; Fuchs, Roswitha; Tesch, Hans; Krabisch, Petra; Brucker, Sara; Fehm, Tanja N; Janni, Wolfgang; Kümmel, Sherko; Lüftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Voges, Claudia; Schubert, Jörg; Fasching, Peter A
    RIBECCA - A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole : Results of the third interim analysis
    In: Cancer Research Jg. 80 (2020) Nr. 4,
    ISSN: 1538-7445; 0008-5472
  • Thomas, M.; Griesinger, F.; Schuler, Martin; Gainor, J. F.; Curigliano, G.; Kim, D.-W.; Lee, D. H.; Besse, B.; Baik, C. S.; Doebele, R. C.; Cassier, P.; Lopes, G.; Tan, D. S.-W.; Garralda, E.; Paz-Ares, L.; Chul Cho, B.; Gadgeel, S. M.; Liu, S. V.; Turner, C. D.; Subbiah, V.;
    Registrational dataset from the phase 1/2 ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion plus non-small-cell lung cancer (NSCLC)
    Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,
    In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 141 - 142
    ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X
  • Hu, M.; Subbiah, V.; Wirth, L.J.; Schuler, Martin; Mansfield, A.S.; Brose, M.S.; Curigliano, G.; Leboulleux, S.; Zhu, Viola W.; Keam, Bhumsuk; Matos, I.; Lin, C-C.; Adkins, Douglas R.; Baik, C.S.; Lopes, G.; Godbert, Y.; Sarker, Debashis; Zhang, H.; Turner, C.; Taylor, M.
    Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S1084
    ISSN: 0923-7534
  • Keam, B.; Hu, M. I.; Subbiah, V.; Wirth, L.; Schuler, Martin; Mansfield, A. S.; Brose, M. S.; Curigliano, G.; Leboulleux, S.; Zhu, V. W.; Matos, I.; Adkins, D.; Baik, C. S.; Lopes, G.; Godbert, Y.; Sarker, D.; Zhang, H.; Turner, C. D.; Taylor, M. H.; Lin, C.-C.;
    Results from the registrational phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET mutation-positive medullary thyroid cancer (RET+ MTC)
    ESMO Asia Virtual Congress 2020 ; 20-22 November 2020,
    In: Annals of Oncology Jg. 31 (2020) Nr. Supplement 6, S. S1413 - S1414
    ISSN: 0923-7534; 1569-8041
  • Darwiche, Kaid; Theegarten, Dirk; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel; Aigner, Clemens; Karpf-Wissel, Rüdiger
    The impact of needle choice on molecular analysis of ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in NSCLC
    In: European Respiratory Journal Jg. 56 (2020) Nr. Suppl. 64,
    ISSN: 1399-3003; 0903-1936
  • Kasper, Stefan; zur Hausen, Gerrit; Stein, Alexander; Stintzing, Sebastian; Berger, Andreas; Loges, Sonja; Hofheinz, Ralf; Trarbach, Tanja; Graeven, Ullrich; Fischer von Weikersthal, Ludwig; Goetze, Thorsten Oliver; Hagen, Volker A.; Burock, Susen; Hoffmeister, Albrecht; Dechow, Tobias Nicolaas; Pauligk, Claudia; Virchow, Isabel; Siveke, Jens; Al-Batran, Salah-Eddin; Schuler, Martin
    A phase IIb study of ramucirumab in combination with TAS102 versus TAS102 monotherapy in metastatic, chemotherapy refractory colorectal cancer patients : The RAMTAS trial of the German AIO (KRK-0316)
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. TPS3617 - TPS3617
    ISSN: 0732-183X; 1527-7755
  • Michels, Sebastian Yves Friedrich; Nogova, Lucia; Deschler-Baier, Barbara; Felip, Enriqueta; Rodriguez-Abreu, Delvys; Rosell, Rafael; Sebastian, Martin; Schuler, Martin; Wermke, Martin; Fischer, Rieke Nila; Koleczko, Sophia; Abdulla, Diana S.Y.; Riedel, Richard; Scheffler, Matthias; Fassunke, Jana; Hellmich, Martin; Merkelbach-Bruse, Sabine; Buettner, Reinhard; Wolf, Juergen
    EATON: An open-label, multicenter, phase I dose-escalation trial of nazartinib (EGF816) and trametinib in patients with EGFR-mutant non-small cell lung cancer – preliminary data on safety and tolerability
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. e20577 - e20577
    ISSN: 0732-183X; 1527-7755
  • Joerger, Markus; Cho, Byoung Chul; Mach, Nicolas; Caballero, Cristina; Soo, Ross A.; Wirth, Manfred; Sayehli, Cyrus; Navarro, Alejandro; Keam, Bhumsuk; Piciu, Ana-Maria; Bender, Sebastian; Nogai, Hendrik; Ellinghaus, Peter; Schuler, Martin
    Early clinical experience with the pan-FGFR inhibitor rogaratinib in patients with non-small cell lung cancer selected based on FGFR mRNA expression levels
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. e20661 - e20661
    ISSN: 0732-183X; 1527-7755
  • Nothdurft, S.; Breitenbücher, Frank; Okimoto, R.; Bivona, T.; Grüner, Barbara M.; Hoelzel, M.; Forster, J.; Kalmbach, S.; Schramm, Alexander; Schuler, Martin
    MA17.07 Identification of AHR as a Novel Regulator of Lung Cancer Metastasis
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S319
    ISSN: 1556-1380; 1556-0864
  • O'Byrne, K.; Yang, J.C.; Wu, Y.; Hirsh, V.; Yamamoto, N.; Popat, S.; Tamiya, A.; Märten, A.; Schuler, Martin
    P2.14-60 Afatinib in EGFR Mutation-Positive NSCLC : Activity in Patients with Brain Metastases, and Impact on CNS Progression/Spread
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, S. 855
    ISSN: 1556-0864
  • Nusch, Arnd; Decker, Thomas; Reinisch, Mattea; Hartkopf, Andreas D.; Heinrich, Bernhard; Kurbacher, Christian M.; Fuchs, Roswitha Dorothea; Tesch, Hans; Krabisch, Petra; Brucker, Sara; Fehm, Tanja N.; Janni, Wolfgang; Kümmel, Sherko; Luftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Voges, Claudia; Schubert, Joerg; Fasching, Peter A.
    RIBECCA: A phase IIIb, multicenter, open label study for women with estrogen receptor-positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole—Results of the second interim analysis.
    In: Journal of Clinical Oncology Jg. 37 (2019) Nr. 15, S. 1061 - 1061
    ISSN: 0732-183X; 1527-7755
  • Sebastian, M.; Schuler, Martin; Schulz, C.; Deschler-Baier, B.; Kimmich, M.; Hilgert-Daute, K.; Griesinger, F.;
    Adverse events self-reported by patients with advanced non-small cell lung cancer treated with osimertinib or chemotherapy in the AURA3 trial
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 111
    ISSN: 2296-5270; 2296-5262
  • O'Byrne, K.; Yang, JCH; Wu, Y. L.; Hirsh, V.; Yamamoto, N.; Popat, S.; Tamiya, A.; Maerten, A.; Schuler, Martin;
    Afatinib for patients with EGFR mutation-positive (EGFRm plus ) NSCLC : Activity in patients with baseline brain metastases and impact on the rate of central nervous system (CNS) progression or spread
    COSA's 45th Annual Scientific Meeting, Mesothelioma and Gastro‐Intestinal Cancers: Technology and Genomics, 13–15 November 2018, Perth Australia,
    In: Asia-Pacific Journal of Clinical Oncology Jg. 14 (2018) Nr. Suppl. 7, S. 159 - 160
    ISSN: 1743-7555; 1743-7563
  • O'Byrne, K.; Yang, J. C-H; Wu, Y-L; Hirsh, V.; Yamamoto, N.; Popat, S.; Tamiya, A.; Maerten, A.; Schuler, Martin;
    Central Nervous System or Systemic Progression Analysis for EGFR Mutation-Positive NSCLC Patients Receiving Afatinib in LUX-Lung 3, 6, and 7
    Konferenz Medical Oncology Group of Australia Incorporated Annual Scientific Meeting, New Directions in Personalised Cancer Therapy; 1–3 August 2018; Adelaide, Australia,
    In: Asia-Pacific Journal of Clinical Oncology Jg. 14 (2018) Nr. Supplement 3, S. 69
    ISSN: 1743-7563; 1743-7555
  • Cao, J.; Wiesweg, Marcel; Fuchs, M.; Stein, A.; Karthaus, M.; Lettmaier, S.; Kretzschmar, A.; Draube, A.; Ettrich, T.; Rüssel, J.; Müller, C.; Rafiyan, M.-R.; Borchert, K.; Schuler, Martin; Kasper, Stefan;
    Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 289
    ISSN: 2296-5262; 2296-5270
  • Slaski, C.; Kasper, Stefan; Paul, Andreas; Gerken, G.; Schmid, Kurt Werner; Meiler, Johannes; Teckelnborg, K.; Dechene, Alexander; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.;
    Evaluation of prognostic markers in patients (pts) with advanced gastric cancer (GC) and adenocarcinoma of the gastroesophageal junction (AEG) treated with systemic chemothearpy (ctx) at the West German Cancer Center
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 67
    ISSN: 2296-5270; 2296-5262
  • Exner, J.-P.; Nadjm, S.; Gauler, Thomas; Pöttgen, Christoph; Krebs, B.; Cheufou, D.; Darwiche, Kaid; Metzenmacher, M.; Theegarten, Dirk; Umutlu, Lale; Hoffmann, Andreas-Claudius; Oezkan, F.; Aigner, Clemens; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;
    Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 109 - 110
    ISSN: 2296-5270; 2296-5262
  • Nadjm, S.; Exner, J. P.; Gauler, Thomas; Pöttgen, Christoph; Darwiche, Kaid; Cheufou, D.; Krebs, B.; Metzenmacher, M.; Oezkan, F.; Rebmann, Vera; Umutlu, Lale; Deuschl, C.; Li, Y.; Lahner, Harald; Christoph, Daniel; Hoiczyk, M.; Witzke, Oliver; Hoffmann, Andreas-Claudius; Aigner, Clemens; Theegarten, Dirk; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;
    Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 108
    ISSN: 2296-5270; 2296-5262
  • Waberer, Lisa; Homann, Nils; Wirtz, Ralph M.; Schmalenberg, Harald; Haag, Georg Martin; Schuler, Martin; Kasper, Stefan; Goetze, Thorsten Oliver; Pauligk, Claudia; Hofheinz, Ralf; Al-Batran, Salah-Eddin
    PD-L1 mRNA expression in patients with resectable gastric cancer and adenocarcinoma of the oesophago-gastric junction undergoing perioperative chemotherapy : Results from the FLOT4 phase III trial of the AIO
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. e24277 - e24277
    ISSN: 0732-183X; 1527-7755
  • Reis, Henning; Niedworok, Christian; Wiesweg, Marcel; Schuler, Martin; Rübben, Herbert; Hadaschik, Boris; Schmid, Kurt Werner; Szarvas, Tibor;
    Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
    Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,
    In: Modern Pathology Jg. 31 (2018) Nr. Suppl. 2, S. 378
    ISSN: 0893-3952; 1530-0285
  • Fasching, Peter A.; Nusch, Arnd; Heinrich, Bernhard; Brucker, Sara; Decker, Thomas; Kurbacher, Christian M.; Tesch, Hans; Krabisch, Petra; Mundhenke, Christoph; Fehm, Tanja N.; Janni, Wolfgang; Lueftner, Diana; Schneeweiss, Andreas; Schuler, Martin; Guderian, Gernot; Voges, Claudia; Schubert, Joerg; Kummel, Sherko
    RIBECCA: A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole : Results of the first interim analysis
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 1051
    ISSN: 0732-183X; 1527-7755
  • Joerger, Markus; Cassier, Philippe Alexandre; Penel, Nicolas; Cathomas, Richard; Richly, Heike; Schostak, Martin; Janitzky, Andreas; Wermke, Martin; Nogova, Lucia; Tai, David Wai-Meng; Sayehli, Cyrus; Grüllich, Carsten; Grande, Enrique; Navarro, Alejandro; Park, Se Hoon; Nogai, Hendrik; Bender, Sebastian; Ellinghaus, Peter; Schuler, Martin
    Rogaratinib in patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression and effects of mutations in the FGFR signaling pathway
    In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 4513 - 4513
    ISSN: 0732-183X; 1527-7755
  • Schuler, Martin; Cassier, P.; Penel, N.; Cathomas, R.; Richly, Heike; Schostak, M.; Janitzky, A.; Wermke, M.; Nogova, L.; Tai, D.; Sayehli, C.; Grüllich, C.; Grande, E.; Navarro, A.; Park, S. H.; Nogai, H.; Bender, S.; Ellinghaus, P.; Joerger, M.;
    Rogaratinib in patients with advanced urothelial carcinomas selected for tumor FGFR mRNA expression and impact of mutations in the FGFR signaling pathway
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; Wien, 28. September - 2. Oktober 2018,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 321
    ISSN: 2296-5270; 2296-5262
  • Wiesweg, Marcel; Reis, Henning; Köster, T.; Goetz, M.; Worm, K.; Herold, T.; Paul, Andreas; Dechene, Alexander; Schumacher, B.; Markus, P.; Virchow, I.; Kostbade, K.; Wolf, N.; Zaun, G.; Metzenmacher, M.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan;
    Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 55
    ISSN: 2296-5270; 2296-5262
  • Stein, G.; Stelmach, Patrick; Kasper, Stefan; Paul, Andreas; Wedemeyer, Heiner H.; Schmid, Kurt Werner; Schumacher, B.; Markus, P.; Siffert, Winfried; Schuler, Martin; Bachmann, Hagen Sjard; Virchow, I.;
    The prognostic impact of UDP-glucuronyltransferase 1A1*1 (UGT1A1*1) polymorphism in patients with advanced colorectal and non-colorectal cancer treated with irinotecan-based systemic chemotherapies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,
    In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 122 - 123
    ISSN: 2296-5262; 2296-5270
  • Schuler, Martin; Nogova, L.; Heidenreich, A.; Tai, D.; Cassier, P.; Richly, Heike; Cho, B. C.; Sayehli, C. M.; Navarro, A.; Bender, Stefan; Ocker, M.; Nogai, H.; Wagner, A.; Ince, S.; Ellinghaus, P.; Joerger, M.
    Anti-tumor activity of the pan-FGFR inhibitor rogaratinib in patients with advanced urothelial carcinomas selected based on tumor FGFR mRNA expression levels
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
    ISSN: 0923-7534; 1569-8041
  • Sahin, U.; Schuler, Martin; Bauer, Sebastian; Krilova, A.; Utsch, M.; Huber, C.; Tureci, O.
    First-in-human study of IMAB362, an anti-claudin 18.2 monoclonal antibody, in patients with advanced gastroesophageal cancer
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
    ISSN: 0923-7534; 1569-8041
  • Schuler, Martin
    Liquid Biopsies for Dynamic Monitoring of EGFR Mutations in Lung Cancer
    In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, Suppl., S. 85
    ISSN: 1556-1380; 1556-0864
  • Hamacher, R.; Kampfe, D.; Ahrens, M.; Reuter-Jessen, K.; Schuler, Martin; Schildhaus, H. U.; Bauer, Sebastian
    PD-L1 inhibition - a new therapeutic opportunity in cutaneous angiosarcoma?
    In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5,
    ISSN: 0923-7534; 1569-8041
  • Luckerath, M.; Kasper, Stefan; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Meiler, Johannes; Wiesweg, M.; Neuhaus, I.; Dechene, Alexander; Mende, B.; Schumacher, B.; Markus, P.; Schuler, Martin; Virchow, I.;
    Evaluation of prognostic markers in patients (pts) with metastatic colorectal cancer (mCRC) treated with a bevacizumab (bev) based chemotherapy (ctx) at the West German Cancer Center
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 77
    ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X
  • Pogorzelski, M.; Hilser, T.; Ting, Saskia; Vossebein, I.; Gauler, Thomas; Abendroth, A.; Lang, Stephan; Stuck, Boris; Abu-Jawad, J.; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan
    Evaluation of systemic inflammatory response (SIR) markers in recurrent or metastatic head and neck squamous cell carcinoma (r/m HNSCC)
    In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 3, S. 307 - 308
    ISSN: 2296-5270
  • Abendroth, A.; Markus, M.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan;
    Evaluation of systemic inflammatory response (SIR) markers in advanced biliary tract cancer (ABTC)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 5 - 6
    ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240
  • Markus, M.; Kasper, Stefan; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Schumacher, B.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Abendroth, A.
    Evaluation of systemic inflammatory response (SIR) markers in pancreatic ductal adenocarcinoma (PDAC)
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. S 5, Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz, S. 4 - 5
    ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262
  • Thomas, M.; Schuler, Martin; Potzner, M.; Szczudlo, T.; Sutradhar, S.; Yovine, A.; Wolf, J.;
    Experience from the ASCEND-1 trial : Ceritinib in patients (Pts) with ALK-rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) and brain metastases
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 270
    ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262
  • Pöttgen, Christoph; Stuschke, Martin; Gauler, Thomas; Welter, Stefan; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl. 1, S. 36 - 37
    ISSN: 0179-7158; 1439-099X
  • Falkenhorst, J.; Treckmann, Jürgen Walter; Nguyen, B. P.; Podleska, Lars; Reis, A. C.; Virchow, I.; Schuler, Martin; Bauer, Sebastian;
    Longitudinal analysis of the impact of the introduction of tyrosine kinase inhibitor therapy on overall survival of patients with gastrointestinal stromal tumors treated at the West German Cancer Center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 167 - 167
    ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262
  • Abendroth, A.; Noureddine, R.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Dechene, Alexander; Schumacher, B.; Kaiser, Gernot Maximil; Schuler, Martin; Kasper, Stefan;
    Prognostische Faktoren bei Patienten mit fortgeschrittenen Pankreaskarzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben.
    121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V. 18. - 21. April 2015, Mannheim,
    In: Der Internist Jg. 56 (2015) Nr. S1, S. 38 - 39
    ISSN: 0020-9554; 1432-1289
  • Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Bockisch, Andreas; Dechene, Alexander; Forsting, Michael; Schuler, Martin; Kasper, Stefan;
    Prognostische Faktoren bei Patienten mit fortgeschrittenen cholangiozellulären Karzinomen, die am Westdeutschen Tumorzentrum (WTZ) sequentielle Chemotherapien erhalten haben
    121. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 18. - 21. April 2015, Mannheim,
    In: Der Internist Jg. 56 (2015) Nr. S 1, S. 37
    ISSN: 1432-1289
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
    21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,
    In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl. 1, S. 23
    ISSN: 0179-7158; 1439-099X
  • Virchow, I.; Podleska, Lars; Pöttgen, Christoph; Reis, A. C.; Steinau, H. U.; Täger, Georg; Farzaliyev, F.; Schuler, Martin; Bauer, Sebastian;
    Solitary fibrous tumors/haemangiopericytoma : Analysis of prognostic factors of 28 patients from a high volume sarcoma center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 246
    ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262
  • Mertins, S.; Virchow, I.; Farzaliyev, F.; Geismar, Dirk; Podleska, Lars; Pöttgen, Christoph; Reis, A. C.; Steinau, H. U.; Stuschke, Martin; Täger, Georg; Treckmann, Jürgen Walter; Schuler, Martin; Bauer, Sebastian;
    TNM-classification for clear cell sarcomas - is it useful?
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,
    In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 247 - 248
    ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262
  • Kasper, Stefan; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Ting, Saskia; Markus, P.; Paul, Andreas; Dechene, Alexander; Kostbade, K.; Schuler, Martin; Trarbach, Tanja;
    Cetuximab biweekly plus mFOLFOX6 as first-line therapy in patients (pts) with KRAS wild-type (wt) metastatic colorectal cancer (mCRC) - Primary endpoint analysis of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 99 - 100
    ISSN: 2296-5262
  • Köhler, Johannes; Schuler, Martin; Gauler, Thomas; Nopel-Dunnebacke, S.; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, M.; Breitenbücher, Frank; Cheufou, D.; Ozkan, F.; Darwiche, Kaid; Hoiczyk, M.; Welter, Stefan; Eberhardt, Wilfried; Teschler, Helmut; Stamatis, Georgios; Hahn, S. A.; Baraniskin, A.;
    Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227
    ISSN: 2296-5262
  • Gauler, Thomas; Nel, I.; Bublitz, K.; Lazaridis, L.; Schuler, Martin; Hoffmann, Andreas-Claudius;
    Circulating tumor cell composition and molecular markers in metastasized renal cell carcinoma (mRCC)
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 131
    ISSN: 2296-5262
  • Jehn, U.; Nel, I.; Schuler, Martin; Gauler, Thomas; Hoffmann, Andreas-Claudius;
    Circulating tumor cell subgroups and outcome in patients with non-small-cell-lung-cancer receiving platinum based treatment
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89
    ISSN: 2296-5262
  • Thomas, M.; Wolf, J.; Schuler, Martin; Goldwasser, M.; Boral, A.; Shaw, A. T.;
    Clinical activity of the ALK inhibitor LDK378 in advanced, ALK-positive NSCLC
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89 - 90
    ISSN: 2296-5262
  • Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Gkika, E.; Hepp, R.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;
    Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl. 1, S. 5 - 6
    ISSN: 0179-7158; 1439-099X
  • Gauler, Thomas; Pogorzelski, M.; Ting, Saskia; Breitenbücher, Frank; Vossebein, I.; Hoffarth, S.; Lang, Stephan; Bergmann, Christoph; Abu Jawad, Jehad; Markowetz, J.; Schmid, Kurt Werner; Schuler, Martin; Kasper, Stefan;
    Impact of human papilloma virus infection on the response of head and neck cancers (HNSCC) to anti-epidermal growth factor receptor (EGFR) antibody therapy
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 76
    ISSN: 2296-5262
  • Kasper, Stefan; Ting, Saskia; Meiler, Johannes; Knipp, Heike; Hohler, T.; Reimer, P.; Steinmetz, T.; Berger, W.; Linden, G.; Worm, K.; Schmid, Kurt Werner; Markus, P.; Paul, Andreas; Dechene, Alexander; Forsting, Michael; Kostbade, K.; Trarbach, Tanja; Schuler, Martin;
    Molecular and clinical predictors of the efficacy of cetuximab in combination with mFOLFOX6 in 1st line treatment of patients (pts) with metastatic colorectal cancer (mCRC) – subgroup analyses of the CEBIFOX trial
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 100 - 101
    ISSN: 2296-5262
  • Kasper, Stefan; Abendroth, A.; Abramczyk, M.; Noureddine, R.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin;
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ)
    Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 51
    ISSN: 2296-5262
  • Welt, Anja; Kasper, Stefan; Tewes, Mitra; Aktas, B.; Hoffmann, Oliver; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Palmer, M. R.; Lee, B. H.; Wendling, J.; Kossow, J.; Scheulen, Max Ernst; Lehnerdt, C.; Kohl, M.; Derks, C.; Slottky, S.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patients
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19
    ISSN: 2296-5262
  • Abendroth, A.; Abramczyk, M.; Nourredine, R.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Baba, Hideo Andreas; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Bockisch, Andreas; Forsting, Michael; Schuler, Martin; Kasper, Stefan;
    Prognostic factors in patients (pts) with advanced cholangiocellular carcinoma (CCC) receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ)
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 122 - 123
    ISSN: 2296-5262
  • Abendroth, A.; Nourredine, R.; Abramczyk, M.; Paul, A.; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Wiesweg, M.; Kaiser, Gernot Maximil; Dechene, Alexander; Schuler, Martin; Kasper, Stefan;
    Prognostic factors in patients with pancreatic cancer receiving sequential chemotherapies (CTX) at the West German Cancer Center (WTZ), one of the 12 Oncology Centers of Excellence in Germany
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 123 - 124
    ISSN: 2296-5262
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Kleinhans, J.; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl 1, S. 17
    ISSN: 0179-7158; 1439-099X
  • Schuler, Martin; Sequist, L. V.; Yang, J. C.; Yamamoto, N.; OByrne, K. J.; Mok, T.; Geater, S. L.; Massey, D.; Wind, S.; OBrien, D.; Lorence, R.; Wu, Y. L.;
    Safety profile of afatinib in first-line therapy of patients with metastatic EGFR mutation-positive (M plus ) non-small cell lung cancer (NSCLC) : Comparative analysis of Asian and non-Asian patients from two randomized trials
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 90
    ISSN: 2296-5262
  • Richly, Heike; Scheulen, Max Ernst; Wiesweg, Marcel; Abendroth, A.; Schuler, Martin; Bauer, Sebastian;
    Systemic treatment of metastatic uveal melanoma - a silver lining on the horizon?
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 118 - 119
    ISSN: 2296-5262
  • Nogova, L.; Gardizi, M.; Bos, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L.; Schildhaus, H. U.; Fuhr, U.; Sos, M.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R.; Buttner, R.; Wolf, J.;
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 92
    ISSN: 2296-5262
  • Nogova, Lucia; Gardizi, Masyar; Bos, Marc Christiaan Allardt; Scheffler, Matthias; Mattonet, Christian; Heukamp, Lukas Carl; Schildhaus, Hans-Ulrich; Fuhr, Uwe; Eberhardt, Wilfried; Reis, Henning; Wiesweg, Marcel; Schmid, Kurt Werner; Schoch, Gernot; Ko, Yon-Dschun; Serke, Monika Heidi; Schuler, Martin H.; Büttner, Reinhard; Wolf, Jürgen
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Clinical Oncology Jg. 32 (2014) Nr. 15, Suppl., S. 8109
    ISSN: 0732-183X; 1527-7755
  • Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;
    Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
    20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,
    In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl. 1, S. 17
    ISSN: 0179-7158; 1439-099X
  • Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derksen, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin;
    WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
    31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,
    In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3
    ISSN: 2296-5262
  • Yang, J. C.; Sequist, L. V.; Geater, S. L.; Tsai, C. M.; Mok, TSK; Schuler, Martin; Yamamoto, N.; Massey, D.; Zazulina, V.; Wu, Y. L.;
    Activity of afatinib in uncommon epidermal growth factor receptor (EGFR) mutations : findings from three trials of afatinib in EGFR mutation-positive lung cancer
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. 141
    ISSN: 1556-1380; 1556-0864
  • Hoiczyk, M.; Herbrik, M.; Grabellus, Florian; Podleska, Lars; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian;
    Brain metastases in soft tissue sarcoma patients - incidence, prognosis and outcome
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 181
    ISSN: 0378-584X; 1423-0240
  • Sequist, L. V.; Yang, J. C.; Yamamoto, N.; OByrne, K.; Schuler, Martin; Mok, T.; Geater, S. L.; Massey, D.; Wind, S.; OBrien, D.; Lorence, R.; Wu, Y. L.;
    Comparative safety profile of afatinib in asian and non-asian patients with EGFR mutation-positive (EGFR M plus) non-small cell lung cancer (NSCLO)
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. 1197
    ISSN: 1556-1380; 1556-0864
  • Schuler, Martin; Yang, J. C.; Sequist, L. V.; Hirsh, V.; OByrne, K.; Yamamoto, N.; Massey, D.; Shahidi, M.; Zazulina, V.; Mok, T.;
    Effiacy of afatinib vs. chemotherapy in treatment-naive patients with non-small cell lung cancer (NSCLC) harbouring activating EGFR mutations with or without metastatic brain disease
    15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S299 - S300
    ISSN: 1556-1380; 1556-0864
  • Kasper, Stefan; Breitenbücher, Frank; Markowetz, J.; Reis, Henning; Ting, Saskia; Worm, K.; Meiler, Johannes; Schmid, Kurt Werner; Trarbach, Tanja; Schuler, Martin;
    Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 116 - 117
    ISSN: 0378-584X; 1423-0240
  • Abendroth, A.; Abramczyk, M.; Paul, Andreas; Gerken, Guido; Schmid, Kurt Werner; Markus, P.; Meiler, Johannes; Tometten, M.; Wiesweg, Marcel; Kaiser, Gernot Maximil; Dechene, Alexander; Trarbach, Tanja; Schuler, Martin; Kasper, Stefan;
    Outcome of patients (pts) with advanced pancreaticobiliary cancers treated with sequential chemotherapies at the West German Cancer Center (WTZ), one of the 11 Oncology Centers of Excellence in Germany
    17 Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 263
    ISSN: 0378-584X; 1423-0240
  • Tewes, Mitra; Kasper, Stefan; Aktas, B.; Hoffmann, A.; Wiesweg, M.; Ting, Saskia; Reis, Henning; Worm, K.; Richly, Heike; Hense, Jörg; Kern, P.; Scheulen, Max Ernst; Skottky, S.; Peters, M.; Schlegel, R.; Lee, B. H.; Palmer, M. R.; Monahan, J. E.; Haus, U.; Schmid, Kurt Werner; Kimmig, Rainer; Schuler, Martin; Welt, Anja;
    Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Oncology Research and Treatment Jg. 36 (2013) Nr. Suppl. 7, S. 157
    ISSN: 0378-584X; 1423-0240
  • Nel, I.; Gauler, Thomas; Nickel, A.; Eberhardt, Wilfried; Thomale, Jürgen; Schuler, Martin; Hoffmann, A.;
    Prä-therapeutische ex-vivo Reparatur Kinetiken von Cisplatin-DNA-Addukten in Zirkulierenden Tumorzellen als Platin-Resistenz Test
    119. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 06. - 09. April 2013, Wiesbaden,
    In: Der Internist Jg. 54 (2013) Nr. Suppl. 1, S. 95 - 96
    ISSN: 0020-9554
  • Nogova, L.; Gardizi, M.; Bos, MCA; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H. U.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R. K.; Buttner, R.; Wolf, J.
    TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Onkologie / Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich Jg. 36 (2013) Nr. Suppl. 7, S. 30
    ISSN: 0378-584X; 1423-0240
  • Mühlenberg, Thomas; Grunewald, S.; Schuler, Martin; Bauer, Sebastian;
    Targeting glucose metabolism by 2-Deoxyglucose in Gastrointestinal Stromal Tumors
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,
    In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 246
    ISSN: 0378-584X; 1423-0240
  • Nogova, L.; Bos, M.; Gardizi, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Buttner, R.; Wolf, J.
    Try : a phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
    In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S914 - S915
    ISSN: 1556-1380; 1556-0864
  • Wolf, Jürgen; LoRusso, Patricia M.; Camidge, Ross D.; Perez, Jose Manuel; Tabernero, Josep; Hidalgo, Manuel; Schuler, Martin; Tian, Gary G.; Soria, Jean Charles; Delord, Jean Pierre; Campone, Mario; Bachelot, Thomas; van der Noll, Ruud; Ringeisen, Francois P.; Nogova, Lucia; Sequist, Lecia V.; Schellens, Jan H. M.
    A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors
    In: Cancer Research / AACR 103rd Annual Meeting 2012 ; Mar 31‐Apr 4, 2012, Chicago Jg. 72 (2012) Nr. 8, Suppl., S. LB - 122
    ISSN: 0008-5472; 1538-7445
  • Christoph, Daniel C.; Asuncion, Bernadette Reyna; Wynes, Murry; Gauler, Thomas C.; Wohlschläger, Jeremias; Theegarten, Dirk; Welter, Stefan; Tran, Cindy; Hassan, Biftu; Loewendick, Heike; Peglow, Anja; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-α-glutamate synthetase and thymidylate synthase are associated with clinical outcome from pemetrexed-based therapy in advanced non-small cell lung cancer (NSCLC)
    In: Cancer Research / AACR 103rd Annual Meeting 2012 ; Mar 31‐Apr 4, 2012, Chicago Jg. 72 (2012) Nr. 8, Suppl., S. 1713
    ISSN: 0008-5472; 1538-7445
  • Simon, Susanne; Fererra, Loretta; Galietta, Luis; Grabellus, Florian; Breitenbücher, Frank; Schuler, Martin; Fletcher, Jonathan; Bauer, Sebastian
    Functional characterization of DOG1 in Gastrointestinal Stromal Tumors (GIST)
    In: Cancer Research / AACR 103rd Annual Meeting 2012 ; Mar 31‐Apr 4, 2012, Chicago Jg. 72 (2012) Nr. 8, Suppl., S. 1824
    ISSN: 0008-5472; 1538-7445
  • Falkenhorst, Johanna; Mühlenberg, Thomas; Simon, Susanne; Ecken, Sonja; Henze, Jörn; Grabellus, Florian; Breitenbücher, Frank; Schuler, Martin; Fletcher, Jonathan A.; Bauer, Sebastian
    Inhibitors of apoptosis (IAPs) in gastrointestinal stromal tumors
    In: Cancer Research / AACR 103rd Annual Meeting 2012 ; Mar 31‐Apr 4, 2012, Chicago Jg. 72 (2012) Nr. 8, Suppl., S. 3855 - 3855
    ISSN: 0008-5472; 1538-7445
  • Schuler, Martin; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O’Byrne, Ken; Hirsh, Vera; Mok, Tony; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Sequist, Lecia
    LUX-lung 3 : A randomized, open-label, phase III study of afatinib vs pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations
    In: Lung Cancer / Central European Lung Cancer Conference ; Prague, June 24-27, 2012 Jg. 77 (2012) Nr. Suppl. 1, S. S25 - S26
    ISSN: 0169-5002; 1872-8332
  • Markova, B.; Hahnel, P. S.; Herbertz, S.; Schuler, Martin; Breitenbücher, Frank
    Influence of Everolimus and Pemetrexed on Thymidylate Synthase expression as well as on Proliferation and survival of non-small cell ling Cancer Cells
    In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. Suppl. 1, S. S56 - S57
    ISSN: 1556-0864; 1556-1380
  • Hilger, Ralf A.; Köhler, Johannes; Kalkavan, H.; Richly, Heike; Hoffmann, Andreas-Claudius; Heinrichs, D.; Azaouagh, A.; Schuler, Martin; Trarbach, Tanja;
    Interpatient pharmacokinetic variability of 5-FU within metastatic and adjuvant colon cancer patients : First results from the West German Cancer Center
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 173
    ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270
  • Nguyen, B. P.; Grabellus, Florian; Hoiczyk, M.; Täger, Georg; Schuler, Martin; Bauer, Sebastian;
    Metastasectomy in patients with GIST in the era of imatinib - improved survival?
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 108
    ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270
  • Even, A.; Kasper, Stefan; Breitenbucher, F.; Pogorzelski, M.; Hoffarth, S.; Trarbach, Tanja; Schuler, Martin;
    Targeting NF-kappa B and PLK-1 to overcome RAS-mediated resistance to anti-EGFR antibody therapy in colorectal cancer
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,
    In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 33
    ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262
  • Beiträge in Sammelwerken und Tagungsbänden

  • Taube, Christian; Schuler, Martin
    Apoptosis in the Physiology and Diseases of the Respiratory Tract
    In: Apoptosis: Physiology and Pathology / Reed, John; Green, Douglas R. 2011, S. 221 - 230
    ISBN: 978-0-521-88656-7
  • Poster / Posterbeiträge

  • Stockhammer, P.; Ho, C.S.L.; Bankfalvi, Agnes; Plönes, T.; Hegedus, L.; Schuler, Martin; Aigner, Clemens; Schramm, Alexander; Hegedus, B.
    P1.14-43 A Novel Patient Derived Synchronous Cell Pair with Different Mutations in an ALK-Rearranged Lung Adenocarcinoma Underlines Tumor Heterogeneity
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S571 - S572
    ISSN: 1556-1380
  • Zaatar, M.; Stork, T.; Fangmann, L.; Martens, A.; Collaud, S.; Mardanzai, K.; Plönes, T.; Valdivia, D.; Schuler, Martin; Stuschke, Martin; Darwiche, Kaid; Hegedus, B.; Aigner, Clemens
    P2.01-94 Advanced Age and High Modified Glasgow Prognostic Score Are Associated with Increased Complications After Pneumonectomy
    In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S677
    ISSN: 1556-1380
  • Ölschläger, Katrin; Grabellus, Florian; Schnell, Rainer; Geffken, Mareike; Hoiczyk, Mathias; Ahrens, Marit; Podleska, Lars; Täger, Georg; Treckmann, Jürgen Walter; Pöttgen, Christoph; Schuler, Martin; Bauer, Sebastian;
    Chemotherapie bei resektablen Weichteilsarkomen mit komplexem Karyotyp : eine Single-Center Analyse
    The annual meeting of the German, Austrian and Swiss Society of Haematology and Oncology, 19.-23.10.2013, Stuttgart,
    Stuttgart (2013)